WO2022124973A1 - A colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating - Google Patents
A colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating Download PDFInfo
- Publication number
- WO2022124973A1 WO2022124973A1 PCT/SE2021/051225 SE2021051225W WO2022124973A1 WO 2022124973 A1 WO2022124973 A1 WO 2022124973A1 SE 2021051225 W SE2021051225 W SE 2021051225W WO 2022124973 A1 WO2022124973 A1 WO 2022124973A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- colloidal
- ionic liquid
- particle dispersion
- nanoparticles
- composite particle
- Prior art date
Links
- 239000006185 dispersion Substances 0.000 title claims abstract description 76
- 238000000576 coating method Methods 0.000 title claims abstract description 54
- 239000011248 coating agent Substances 0.000 title claims abstract description 46
- 239000011246 composite particle Substances 0.000 title claims abstract description 33
- 230000003253 viricidal effect Effects 0.000 title claims abstract description 33
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 22
- 239000004599 antimicrobial Substances 0.000 title claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000002608 ionic liquid Substances 0.000 claims abstract description 57
- 239000002245 particle Substances 0.000 claims abstract description 45
- 239000002131 composite material Substances 0.000 claims abstract description 42
- 239000008199 coating composition Substances 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 24
- 239000002082 metal nanoparticle Substances 0.000 claims abstract description 21
- 239000003586 protic polar solvent Substances 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 241000700605 Viruses Species 0.000 claims description 24
- 229910052751 metal Inorganic materials 0.000 claims description 24
- 239000002184 metal Substances 0.000 claims description 24
- 239000003638 chemical reducing agent Substances 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 19
- 229910052802 copper Inorganic materials 0.000 claims description 17
- 239000000178 monomer Substances 0.000 claims description 17
- 239000007921 spray Substances 0.000 claims description 15
- 229910052709 silver Inorganic materials 0.000 claims description 11
- 230000009467 reduction Effects 0.000 claims description 9
- 239000003999 initiator Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 claims description 6
- 230000009849 deactivation Effects 0.000 claims description 6
- 239000012736 aqueous medium Substances 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 5
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- 239000002905 metal composite material Substances 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 125000001425 triazolyl group Chemical group 0.000 claims description 4
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 230000000379 polymerizing effect Effects 0.000 claims description 3
- 125000005207 tetraalkylammonium group Chemical group 0.000 claims description 3
- 125000005497 tetraalkylphosphonium group Chemical group 0.000 claims description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 241001678559 COVID-19 virus Species 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 description 91
- 239000010949 copper Substances 0.000 description 75
- 239000000243 solution Substances 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 239000011521 glass Substances 0.000 description 19
- 229920000642 polymer Polymers 0.000 description 19
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 18
- 238000000604 cryogenic transmission electron microscopy Methods 0.000 description 14
- 238000005507 spraying Methods 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 239000000758 substrate Substances 0.000 description 11
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 10
- 210000002845 virion Anatomy 0.000 description 10
- 238000001246 colloidal dispersion Methods 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 238000006722 reduction reaction Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000002411 thermogravimetry Methods 0.000 description 7
- 238000004627 transmission electron microscopy Methods 0.000 description 7
- 241000711573 Coronaviridae Species 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000002441 X-ray diffraction Methods 0.000 description 6
- 230000000840 anti-viral effect Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000025721 COVID-19 Diseases 0.000 description 5
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 239000010415 colloidal nanoparticle Substances 0.000 description 5
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 5
- 239000000645 desinfectant Substances 0.000 description 5
- WVFLGSMUPMVNTQ-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-[[1-(2-hydroxyethylamino)-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCO WVFLGSMUPMVNTQ-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- -1 silver ions Chemical class 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000006059 cover glass Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 230000007480 spreading Effects 0.000 description 4
- 238000003892 spreading Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- PBLNBZIONSLZBU-UHFFFAOYSA-N 1-bromododecane Chemical compound CCCCCCCCCCCCBr PBLNBZIONSLZBU-UHFFFAOYSA-N 0.000 description 3
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 3
- 241000494545 Cordyline virus 2 Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000004626 scanning electron microscopy Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000001757 thermogravimetry curve Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 2
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001879 copper Chemical class 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 238000000235 small-angle X-ray scattering Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-O 1-ethenylimidazole;hydron Chemical group C=CN1C=C[NH+]=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-O 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- RXWOHFUULDINMC-UHFFFAOYSA-N 2-(3-nitrothiophen-2-yl)acetic acid Chemical compound OC(=O)CC=1SC=CC=1[N+]([O-])=O RXWOHFUULDINMC-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 208000003508 Botulism Diseases 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 241000941423 Grom virus Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000709721 Hepatovirus A Species 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000000805 composite resin Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000004815 dispersion polymer Substances 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229910001922 gold oxide Inorganic materials 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- 229940019931 silver phosphate Drugs 0.000 description 1
- 229910000161 silver phosphate Inorganic materials 0.000 description 1
- CHACQUSVOVNARW-LNKPDPKZSA-M silver;(z)-4-oxopent-2-en-2-olate Chemical compound [Ag+].C\C([O-])=C\C(C)=O CHACQUSVOVNARW-LNKPDPKZSA-M 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000002691 unilamellar liposome Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000007482 viral spreading Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
Definitions
- the present disclosure relates to a colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating, a coating composition for antimicrobial and virucidal surface coating, a method for applying the coating composition, uses of the colloidal composite particle dispersion and/or the coating composition, and a method for preparation of a colloidal composite particle dispersion as defined in the independent claims.
- WHO World Health Organization declared in March 2020 a pandemic and a global crisis caused by a new coronavirus, SARS-CoV-2 (COVID-19) that was discovered to be the cause of a rapidly spreading outbreak of respiratory disease.
- SARS-CoV-2 COVID-19
- Coronaviruses are so named because of their characteristic solar corona (crown-like) appearance when observed under an electron microscope.
- the SARS-CoV-2 virion is spherical with an average size of 78 nm.
- SARS-CoV-2 is a delicate but highly contagious virus capable of spreading primarily from person to person around the world. It can also spread when an infected person coughs or sneezes and a droplet lands on a surface or object, which is touched by a person and then the person's nose, mouth or eyes.
- hygiene measures are recommended to prevent the spread of disease, especially in areas where individuals might be in contact with patients or contaminated fomites. Washing hands with soap and water or with alcohol-based hand rubs are effective for interrupting virus transmission.
- EP-A-3462526 discloses a biomedically active material, comprising atomically dispersed metal species on the surface of a carbon material.
- the metal species are dispersed in an ionic liquid.
- the carbon atoms have a sp 2 hybridization.
- the intended use is for example as a coating in an electrode for oxidation.
- US2020239709A1 discloses a composite resin comprising silver nanoparticles and a polymer.
- the silver nanoparticles are formed by reduction of silver ions.
- the resin can be used e.g. as an antimicrobial surface coating.
- KR101465866B1 discloses polymer-silver nanoparticles including 2-(2-acetoxy) ethyl methacrylate and silver.
- the nanoparticles can be used for antibiosis activity, as a coating material.
- antimicrobial surface coatings comprising metal ions (such as silver) bound by a polymer are known.
- metal ions such as silver
- such coatings have limited utility, e.g. under wet conditions.
- the production process of such coatings typically require the use of multiple chemicals/solvents that are hazardous and/or environmentally challenging. There is thus a need for improved surface coatings for these purposes. Summary
- a colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating, comprising a composite of: (a) a colloidal poly(ionic liquid) particle that is molecularly insoluble in water and comprises a n-alkyl substituent; and (b) metal nanoparticles that are deposited on the poly(ionic liquid) particles; wherein the composite particle is in a polar protic solvent, such as a water-based solution.
- poly(ionic liquid) particles with an alkyl chain substituent typically a long alkyl chain
- an alkyl chain substituent typically a long alkyl chain
- colloidal dispersion can be sprayed onto various surfaces to kill occurring microbes and viruses, such as COVID 19.
- the used poly( ion ic liquid) polymers are not soluble in water (though their particles are waterborne and can be dispersed in water), the formed composite films are stable in both dry and wet condition, e.g. for outdoor surface coating.
- the cation of the polymer particle is chosen from imidazolium, triazolium, tetraalkylammonium and tetraalkylphosphonium.
- the n-alkyl substituent is chosen from the interval of octyl to octadecyl substituent, because these long alkyl chains make the polymer insoluble in water-based solution.
- the n-alkyl substituent is chosen from the interval of dodecyl (C12) to tetradecyl (C14) substituent.
- the metal nanoparticle is chosen from Cu or Ag. In some embodiments the metal nanoparticle is chosen from Cu. These metals have proven to be especially effective for antimicrobial and/or virucidal applications.
- the polar protic solvent is an aqueous media, where the water content is above 50%.
- a coating composition for antimicrobial and virucidal surface coating comprising the colloidal particle dispersion according to any of the embodiments of the first aspect, and optionally additional ingredients such as dye and/or odorant molecule(s), odor control chemical(s), to change color and/or smell, stabilizer(s), surfactant(s) and/or pH modifier(s), wherein the coating composition exhibits water stability.
- hydrophobic fluorescent molecules are included in the composition to improve visibility of the coating surface.
- a method for applying the coating composition According to a third aspect there is provided a method for applying the coating composition.
- the coating composition is for use in spray applications.
- the coating composition is easily applied to suitable surfaces, for which it is desirable to achieve an antimicrobial and/or virucidal activity, thereby limiting or eliminating the risk of e.g. virus spreading and/or contamination.
- the coating composition is applied as a film having a thickness in the interval of 10-500 pm, for indoor and/or outdoor applications.
- Such film can e.g. be used to cover various devices, machines and products in order to limit and/or inactivate the spreading of microbes and/or viruses.
- colloidal composite particle dispersion and/or the coating composition in virucidal applications, such as for deactivation or elimination of COVID 19 at a suitable indoor and/or outdoor surface, is provided.
- a method provided for preparation of a colloidal nanoparticle dispersion comprising the steps of: (a) providing a -ionic liquid monomer with a n-alkyl substituent, wherein n is in the interval from 8 to 18;
- step (c) adding a metal salt to the dispersion of step (b), and
- step (d) reducing the metal salt by adding a reducing agent to the dispersion of step (c) thereby obtaining a colloidal poly(ionic liquid)/metal composite particle dispersion.
- the n-alkyl chain-ionic liquid monomer provided in step (a) is in a concentration of about 0.5-20% (weight).
- the reducing agent of step (d) is added in a 2 molar equivalent ratio to the metal salt to ensure full reduction of metal salts to metal nanoparticles.
- the solution according to the invention is to use poly( ion ic liquid) particles with long alkyl substituent in the repeating unit as carrier of metal (preferably Ag or Cu) species to produce the colloidal poly(ionic liquid)/metal composite particles in polar protic solvent media (preferably aqueous media).
- metal preferably Ag or Cu
- Such colloidal dispersion can be sprayed onto various surface to kill microbes and/or viruses, such as SARS-CoV-2.
- the used poly(ionic liquid) polymers are not soluble in water (though their particles can be dispersed in water), the formed composite films are stable in both dry and wet condition, e.g. for outdoor surface coating.
- the invention provides such material in an environmentally friendly way.
- Such spray liquids can be produced in water as a green solvent and after spray-coating the poly(ionic liquid)/metal colloidal composite particles can resist wet conditions, so that they can be used both indoor and outdoor.
- Figure 1 shows a cryogenic transmission electron microscopy (cryo-TEM) image of the poly(l-n-dodecyl-3-vinylimidazolium bromide) particles.
- the size is around 20-50 nm.
- Figure 2 shows a cryo-TEM image of the poly(ionic liquid)/Cu colloidal composite particles.
- Cu nanoparticles are located onto the poly(ionic liquid) particles.
- the Cu nanoparticles are around 1-4 nm (highlighted by white arrows; the PIL particles are 20- 50 nm in size).
- Figure 3 shows the virucidal activity of surfaces coated with pristine PIL, and a PIL/Cu particle composite.
- Figure 4 schematically illustrates the process of deactivation of SARS-CoV-2 virions by the formed surface coating by PIL/copper composite nanoparticles.
- Figure 5 discloses a 1 H-NMR spectra of poly(3-dodecyl-l-vinylimdiazolium bromide) in CDCh.
- Figure 6 discloses a TGA plot of PIL nanoparticles under air from room temperature to 900 °C
- Figure 7 discloses a schematic representation of the surface spray coating of a glass substrate by an aqueous colloidal dispersion of PIL/Cu composite particles.
- Figure 8 (A, B) discloses cryo-TEM images of the pristine PIL nanoparticles dispersed in aqueous solution.
- Figure 9 A) SEM image of the PIL/Cu composite nanoparticles on a glass substrate, B) Cryo- TEM image of PIL/Cu nanoparticles dispersed in aqueous media. C) XRD patterns of PIL and the PIL/Cu composite nanoparticles, D) TGA curve of the PIL/Cu composite nanoparticles under air from room temperature to 900 °C.
- Figure 10 (A, B) discloses water contact angle measurements of glass substrates coated with PIL nanoparticles, and the PIL/Cu composite nanoparticles, respectively.
- a colloidal dispersion is to be interpreted as a mixture that has particles ranging between 15 nm and 1 mm in diameter, and are essentially evenly distributed throughout the solution.
- a colloidal composite particle dispersion is to be interpreted as a mixture that has particles with combination of two or more materials with different physical and chemical properties ranging between 1 nm and 1 mm in diameter, and are essentially evenly distributed throughout the solution.
- composite is to be interpreted as a combination of two or more materials with different physical and chemical properties.
- antimicrobial is to be interpreted as an agent that kills microorganisms or stops their growth.
- viralucidal is to be interpreted as an agent having the capacity to or tending to destroy or inactivate viruses
- poly(ionic) liquid is to be interpreted as a group of charged polymers that are produced by the polymerization of ionic liquids or by covalent attachment of ionic liquids into the repeating unit of polymers.
- nanoparticle is to be interpreted as particles with their size in the range of 1 to 100 nm.
- water-based solution is to be interpreted as either pure water or a mixture in which water is more than 50% in volume.
- water stability is to be interpreted as the microstructures of the composite film do not change in contact with water.
- solubility in water is to be interpreted as the ability of a solute to molecularly dissolve in water as a solvent.
- suitable surface is to be interpreted as a surface of indoor and/or outdoor type and/or conditions, to which the coating composition and/or the colloidal composite particle disperson can be applied, thereby providing the desired antimicrobial and virucidal effects.
- the first aspect of this disclosure shows a colloidal particle dispersion of 0.01 to 50 % in concentration (weight), preferably of 0.1-10 % (weight) for use in an antimicrobial and virucidal surface coating, comprising a composite of: (a) a poly(ionic liquid) particle comprising a n-alkyl substituent in each repeating unit; and (b) metal nanoparticles that are deposited on the poly(ionic liquid) particles; wherein the composite particle is in a polar protic solvent, such as a water-based solution.
- a polar protic solvent such as a water-based solution.
- the poly(ionic liquid) (“PIL”) particles typically have a size in the interval of 15 nm to 1mm, preferably 15 nm to 100 pm, more preferably 15 nm to 10 pm, and most preferably 20 nm to 1 pm.
- the polymer particles of the invention are typically not molecularly soluble in water. Instead they are dispersible in water.
- the solid content of the colloidal particle dispersion is typically in the interval from 0.01 - 50 % (weight), preferably 1-10 % (weight).
- Poly(ionic liquid) is therefore present in an interval from 0.01 - 50 % (weight), preferably in the interval from 0.1 to 10 % (weight), and more preferably from 1 to 5% (weight).
- Metal nanoparticles are deposited on the poly(ionic liquid) particles at a content in the interval from 0.01-50 wt%, preferably in the interval from 0.1- 20 wt%, and most preferably in the interval from 1-15 wt%,.
- Typical conditions for the surface coating to be efficient are e.g. a temperature in the interval of 0-100 °C, preferably 10-60 °C, more preferably 15-35 °C, and most preferably around room temperature, such as about 20-25 °C.
- the air moisture can e.g. be up to about 95% relative humidity.
- the main mechanism for the coating to be efficient for viruses and microbials works by the release of either Cu 2+ ions or Ag + ions to kill virus or microbes.
- the surface coating of the present invention is active against many different microbes Campylobacter, Clostridium perfringens, E. coli, listeria, salmonella, bacillus cereus, botulism, and shigella and viruses such as SARS-CoV-2, norovirus, and hepatitis A virus..
- the cation of the poly(ionic liquid) particle is chosen from imidazolium, triazolium, tetraalkylammonium and tetraalkylphosphonium, wherein the most preferred cation is imidazolium because it is the most widely reported one in literature and the most widely used in our society.
- the n-alkyl substituent is chosen from the interval of octyl C8 to octadecyl C18 substituent. Most preferred are the C12 and C14 substituents, because the monomers with C12 and C14 alkyl substituents can produce stable poly(ionic liquid) particles at high concentrations above 10 wt%.
- the metal nanoparticle is chosen from Cu or Ag, especially Cu.
- the polar protic solvent is typically an aqueous media, but for some applications the polar protic solvent may also be chosen from e.g. ethanol, isopropanol, ethyl glycol and triethyl glycol.
- the second aspect of this disclosure shows a coating composition for antimicrobial and/or virucidal surface coating, comprising the colloidal particle dispersion according to the first aspect, and optionally additional ingredients such as dye and/or odorant molecule(s), odor control chemical(s), in order to change color and/or smell, stabilizer(s), surfactant(s) and/or pH modifier(s), wherein the coating composition exhibits water stability.
- Hydrophobic fluorescent molecules e.g. carotene and Nile red, can be added to or included in the composition to improve the visibility of the coating surface. These dye molecules are stored in the poly(ionic liquid) particles due to their hydrophobic interaction in the aqueous dispersion.
- the dispersion typically has a concentration in the interval of 0.1-50 % (weight), depending on the application and the desired properties of the coating.
- the dispersion in a low concentration (below 15%) is preferred for coating of a surface with thickness less than 100 micron meters, while the dispersion in a high concentration (above 15%) is favoured for coating of a surface with thickness more than 100 micron meters.
- no other ingredients than the dispersion of the present invention are necessary for obtaining the coating composition.
- the dispersion of the first aspect of the invention can be used as the coating composition, and hence the embodiments and features related to the coating composition will be fully applicable to the dispersion of the invention as such.
- the coating composition of the present invention can be stored under the following conditions: temperature: 2-100 °C under normal pressure, i.e. so that the water phase is prevented from freezing as well as boiling.
- the composition can be stored for a long time, such as months, or even up to about 2 years or more.
- the coating composition can be used in several types of applications and/or methods (also referred to as a third aspect), as long as the overall objective is met, i.e. to provide an antimicrobial and/or virucidal coating on a relevant type of surface (i.e. a target surface).
- the dispersion of the invention may be used in spray applications.
- Such spray contains the polymer/metal composite colloidal particles typically in the concentration of 0.5 to 5 % (weight).
- the metal is Ag or Cu, especially Cu.
- the dispersion can easily be sprayed onto the target surface to be protected. In order to obtain full effect, the surfaces should be fully covered by the coating, i.e. spray should be applied so that the entire target surface is covered and protected, thereby limiting or eliminating the occurrence of microbial and/or viral particles adhering to and being able to survive, grow and/or spread, e.g. so that viruses are prevented from contaminating a surface and spreading to humans and/or animals.
- Typical thickness 5-500 micrometers, even though any thickness outside this interval may also be formed in accordance with the invention.
- the coating can be applied to any surface size, as long as it is practically possible, i.e. that the spray coating machine used or any other device used for applying the material, is adapted to apply the surface size.
- a spray coating machine as disclosed in Example 5
- a surface size of 10 cm x 10 cm can be applied.
- a spray coating machine or device having properties adapted for such surface sizes can be used.
- the skilled persons would be able to understand and adapt the device(s) used for the specific application, e.g. by using and/or adapting spray application devices typically used for other purposes, such as typical spray bottles for personal use and/or spray machines used in automotive industry or in paint applications.
- the coating may be applied to most surfaces.
- a primer may preferably be applied before applying the coating, to increase the binding strength of the coating to the surface.
- the coating composition and/or the colloidal composite particle dispersion is used in virucidal applications, such as for deactivation or elimination of SARS- CoV-2 from a surface.
- the composite material of the invention e.g. in the form of a film
- Such rooms can e.g. be living houses, working areas, trains, and planes or other transport means.
- the film comprising the composite material of the invention can for example be formed as disclosed in detail in Example 5 using a spray coating machine.
- a film has thickness of 5 to 500 micron meters, depending on the solid content of the dispersion.
- dispersion having a high solid content will typically be used for formation of a film having a relatively higher thickness
- a dispersion having a low solid content will typically be used for formation of a film having a relatively lower thickness.
- the fifth aspect of this disclosure shows a method for preparation of a colloidal particle dispersion according to the first aspect, comprising: (a) providing an ionic liquid monomer with a n-alkyl substituent, wherein n is in the interval from 8 to 18; (b) polymerizing the n- alkyl chain ionic liquid monomer in a polar protic solvent such as water-based solution by adding a radical initiator, initiating the polymerization to produce a colloidal poly(n-a I kyl- ionic liquid) particle dispersion; (c) adding a metal salt to the dispersion of step (b), and (d) reducing the metal salt by adding a reducing agent to the dispersion of step (c) to obtain a colloidal poly(ionic liquid)/metal composite particle dispersion.
- a polar protic solvent such as water-based solution
- the n-alkyl chain-ionic liquid monomer is typically provided in step (a) in a concentration of about 0.5 -20 % (weight).
- the ionic liquid monomer is typically synthesized (see Example 2).
- step (b) the water-soluble radical initiator (e.g. V-501, V-50, VA-044, and VA-086) is typically added at a concentration of about 0.5-3 % (weight) of the n-alkyl chain-ionic liquid monomer.
- the water-soluble initiator can easily be purchased. The skilled person would know how to obtain the initiator.
- the metal salt typically a Cu or Ag salt chosen from the list of CuCb, CuBr?, CufOAc /AgOAc, CnfNOsh/AgNC , copper/silver acetylacetonate, and copper/silver phosphate, is typically added in step (c) at 0.1 to 50 % (weight) of the polymer nanoparticles, preferably about 1 to 10 % (weight) of the nanoparticles.
- the reduction of step (d) can be performed in several different ways, as long as the necessary reduction is obtained.
- the metal salt can be reduced by adding a reducing agent to the dispersion of step (b) to obtain the final desired composite dispersion.
- the reducing agent is added in a 2 molar equivalent ratio to the metal salts to ensure the full reduction of metal salts to metal nanoparticles.
- the reducing agent can for example be chosen from sodium borhydride (preferably used at room temperature), vitamin C, citric acid, polyols or hydrazine (N2H4) (preferably used at 80 °C or above).
- sodium borhydride is typically used as reducing agent.
- water-soluble by-products may occur after step (d).
- An additional method step comprising dip-washing the product of step (d) may be introduced to remove such by-products.
- suitable conditions for the preparation of the composite dispersion of the invention are the following:
- the polymerization (step (b)) is typically performed in the interval from 50-90 °C, preferably about 70 °C.
- the reduction (step (d)) is typically performed at a temperature suitable for the chosen reducing agent (reductant), and may vary from about room temperature (15-25 °C) to about 80-100 °C, whatever is suitable for the reducing agent, and as long as the water-based dispersion does not freeze or boil.
- step (b) should typically last for about 12 hours, or as long that is necessary for completion. By using TEM and cryo-TEM, completion of the desired reactions and the obtained structures can be shown.
- the inventors produced poly(ionic liquid) nanoparticles from a long alkyl chain-ionic liquid monomer, 3-n-alkyl-l-vinylimidazolium bromide in water.
- This polymerization forms a stable poly(ionic liquid) nanoparticle dispersion in water, although the poly(ionic liquid) itself is molecularly insoluble thus aggregates into nanoparticles that are dispersed in water.
- Cu salts such as copper acetate, copper chloride or cooper acetylacetonate
- a reductant e.g. hydrazine (N2H4) at 80 °C to reduce the Cu salts into Cu nanoparticles, and these Cu nanoparticles are located on the surface of poly(ionic liquid) nanoparticles (Cu nanoparticles are typically 1-4 nm in size, and polymer nanoparticles are typically 15-50 nm in size).
- This step forms a stable poly(ionic liquid)/Cu colloidal composite particle dispersion.
- FIG. 1 shows a cryogenic transmission electron microscopy (cryo-TEM) image of the synthesized poly(ionic liquid) nanoparticles.
- Figure 2 is a cryo-TEM image of the poly(ionic liquid)/Cu colloidal composite nanoparticles.
- a glass slip with size of 24x24 mm and thickness of 0.5mm was treated with an oxygen Plasma instrument to make the substrate surface hydrophilic and clean for 3 min.
- a spray coating machine a spray machine with pore size of 100 micron meters, a flow rate of 2 ml per min, and a point size of 6.5 cm x 6.5 cm at a distance of 8.5 cm
- the hydrophilic surface of glass slip was coated with C12-Cu Np dispersion for ca. 30 seconds with a film thickness of 5 to 500 micron meters, depending on the solid content of the dispersion and the spray time.
- Cover glasses were placed into a 6-well plate and 10 pL containing a known number of infectious units of SARS-CoV-2 was applied in the center of the glass. The droplet was immediately covered by uncoated cover glass to spread the virus on the whole area. After incubation at specified time, usually 5, 30, and 180 min, 490 pL IX PBS was added to the coverslips, the top coverslip was lifted and the virus-exposed sides of both coverslips were washed with PBS by pipetting 3 times to collect the virus species. The inventors collected the whole washing and used for titer determination. The outcome in Figure 3 shows that within 30 min, 90% of SARS-CoV-2 is deactivated, and 180 min for 99.5% deactivation.
- Example 7 Colloidal dispersion of poly(ionic liquid)/Cu composite particles for protective surface coating against SAR-CoV-2
- the inventors report a waterproof anti-SARS-CoV-2 protective film prepared by spray-coating of an aqueous colloidal dispersion of poly(ionic liquid) /copper (PIL/Cu) composite nanoparticles onto a substrate.
- the PIL dispersion was prepared by suspension polymerization of 3-dodecyl-l-vinylimdiazolium bromide in water at 70 °C.
- the copper acetate salt was added into the PIL nanoparticle dispersion and in-situ reduced into copper nanoparticles anchoring onto the PIL nanoparticles.
- the PIL in bulk is intrinsically insoluble in water and the formed coating is stable in water.
- the formed surface coating by PIL/copper composite nanoparticles was able to deactivate SARS-CoV-2 virions by 90.0% in 30 min and thus may effectively prevent the spread of SARS-CoV-2 through surface contact (see figure 4).
- This method may provide waterborne dispersions for a broad range of antivirus protective surface coatings for both outdoor and indoor applications.
- SARS-CoV-2 severe acute respiratory syndrome coronavirus type 2
- Metal nanoparticles historically have been proven to show a wide range of virucidal and bactericidal activities due to their effectiveness at a low dosage, small size, high surface area, and acting as ion reservoirs to control the release of bioactive ions. Metal nanoparticles demonstrate the capability to generate reactive oxygen species to destroy the virus and attach to DNA or RNA, and accordingly they can prevent the replication of microorganisms.
- metal nanoparticles such as silver (Ag), copper (Cu), iron, iron oxide, gold, and titanium oxide
- Ag nanoparticles are the most widely explored in the literature because of their high effectivity versus infections and high demands in industrial applications.
- Cu nanoparticles with high antimicrobial (especially antifungal), low cost and wide availability and abundance can be alternatively utilized [6-12] . If not surface-protected, a rapid aggregation of a dispersion of native metal nanoparticles can cause a large decrease in their reactivity.
- a common method to overcome this problem is to stabilize metal nanoparticles with organic compounds, such as low molecular weight ligands and chelating polymers by selective functionalization of their surface I 13-17 ].
- Poly(ionic liquidjs (PILs) as a subclass of polyelectrolytes are polymer materials with adjustable physiochemical characteristics due to covalently incorporated ionic liquid-like ion pairs in the polymer chains, and usually possess mechanical stability, durability, ion conductivity and multifunctionality I 18 - 19 ].
- This unique combination broadens the application scope of PILs in comparison to conventional polyelectrolytes in versatile research areas such as biosensors I 20 - 21 !, biomaterials I 22-26 ], energy materials I 27-30 ], just to name a few.
- the self-assembly of PILs has provided new aspects in the direction of functional nanomaterials I 31-34 ].
- the inventors investigated the potential anti-SARS-CoV-2 activity of a composite film consisting of spray-coated PIL/Cu nanoparticles from their aqueous colloidal dispersion. Detailed materials characterization certified the establishment of smaller Cu nanoparticles onto the PIL nanoparticles. The inventor's virucidal activity tests show high virucidal activities of such films against SARS-CoV-2 virions, pointing out potential applications of such spray-coatings for indoor and outdoor surfaces to decline the infection and transmission of SARS-CoV-2 virions via contaminated surfaces.
- Nuclear magnetic resonance (NMR) 1 H-NMR spectra were recorded at room temperature using a Bruker DPX-400 spectrometer operating at 400 MHz. CDChwas used as a solvent for the measurement.
- TEM Transmission electron microscopy
- Cryogenic transmission electron microscopy Cryo-TEM: Cryo-EM specimens were prepared by applying a 4 pL drop of a dispersion sample to Lacey carbon-coated copper TEM grids (200 mesh, Science Services) and plunge-frozen into liquid ethane with an FEI vitrobot Mark IV set at 4 °C and 95% humidity. Vitrified grids were either transferred directly to the microscope cryogenic transfer holder (Gatan 914, Gatan, Kunststoff, Germany) or stored in liquid nitrogen. Imaging was carried out at temperatures around 90 K. The TEM was operated at an acceleration voltage of 200 kV, and a defocus of the objective lens of about 2.5-3 pm was used to increase the contrast.
- X-ray diffraction XRD measurements were carried out using a Bruker D8 diffractometer in the locked coupled mode (20 ranging from 10° to 80°) with Cu Kai radiation. The PIL/Cu composite sample was measured with an air-tight XRD holder from Bruker.
- TGA Thermal gravimetric analysis
- the contact angle was measured using the image of a sessile drop with DI water at the points of intersection (three-phase contact points) between the drop contour and the projection of the surface (baseline) (KRUSS instruments, DSA25E, CA).
- Vero E6 cells maintained in Dulbecco's modified Eagle medium (Gibco) supplemented with 10% fetal calf serum and 1% penicillin-streptomycin and cultured at 37 °C in a humidified incubator with 5% CO2, were washed with PBS, and two-fold serial virus dilutions of SARS- CoV-2 was added in 200 pL minimal essential medium (Invitrogen) supplemented with 0.2% bovine serum albumin, 2 mM L-glutamine, and 20 mM HEPES with periodic shaking for 1 h 37°C.
- Divitrogen minimal essential medium
- bovine serum albumin 0.2% bovine serum albumin
- 2 mM L-glutamine 2 mM L-glutamine
- 20 mM HEPES 20 mM HEPES with periodic shaking for 1 h 37°C.
- the stepwise fabrication of the spray-coating film onto a glass slide with a colloidal dispersion of PIL/Cu composite nanoparticles is provided in Figure 7.
- the colloidal nanoparticle dispersion comprises a composite of PIL nanoparticles containing Cu nanoparticles that are located on PIL nanoparticles.
- the synthesis and characterization details of the PIL used in this study, named poly(l-n-dodecyl-3-vinylimidazolium bromide) are provided in Supporting Information.
- the convenient method to obtain Cu nanoparticles in the solution phase is the chemical reduction of a copper salt by a proper reducing agent.
- reducing agents can be utilized at different reaction temperature, e.g. sodium borohydride at room temperature, hydrazine (N2H4, at 80 °C), and ascorbic acid (vitamin C, at 100 °C) I 40-42 ].
- reaction temperature e.g. sodium borohydride at room temperature
- ascorbic acid vitamin C, at 100 °C
- water-soluble by-products may be generated after the reduction of copper salt.
- An additional step of dip-washing of the film product in clean water for 30 s is added to remove any by-product.
- cryogenic transmission electron microscopy (cryo-TEM) images of the PIL nanoparticles with a long dodecyl substituent on the vinylimidazolium repeating unit in aqueous solution are provided.
- the dark dots represent the PIL nanoparticles in a spherical shape.
- the native inner morphology is clearly distinguishable, where a quasi-spherical onionlike vesicular nanostructure is identified with its size variation in the range of 20-50 nm.
- the dark ring within the nanoparticles represents the ionic mainchain domain, and the higher contrast originates from the Br anion that serves also as a contract agent here.
- the grey ring zones come from the packed alkyl substituents that are of a lower contract in the TEM.
- the number of bilayers of co. 3.42 nm in thickness is countable in the typical range of 4-8 and is dependent on the size of nanoparticles.
- SAXS small-angle X-ray scattering
- FIG. 9A The scanning electron microscopy (SEM) shown in Figure 9A visualizes a composite of PIL/Cu colloidal nanoparticles in a spherical shape with a similar size as the pristine PIL nanoparticles.
- the sample morphology on the glass substrate does not change after the glass plate was immersed in water for 10 minutes, a phenomenon that arises from the insoluble nature of the PIL nanoparticle in water and its strong surface-binding function. But the presence of Cu nanoparticles cannot be demonstrated by SEM due to their rather small size. Therefore, cryo-TEM for the PIL/Cu colloidal composite was employed (Figure 9B). Clearly, Cu nanoparticles of 1-4 nm in size are observed to locate on PIL nanoparticles, highlighted by white arrows.
- thermogravimetric analysis (TGA) of the PIL/Cu colloidal composite in air shows a 5 wt.% mass loss at 250 °C, and then a rapid decomposition up to 600 °C, followed by a constant mass loss till a final residue of 13.7% at 900 °C.
- TGA plot of the pristine PIL nanoparticles shows a complete decomposition already at 600 °C ( Figure S2).
- the difference in mass residue between two samples determines a metallic Cu content of 9.6 wt.% in the PIL/Cu composite particles. This is in good agreement with our combustion-based elemental analysis result of 10.1 wt% of Cu in the composite.
- the virucidal activity of glass substrates coated with pristine PIL, and the composite of PIL/Cu nanoparticles is shown in Figure 10C. Substrates were incubated with SARS-CoV-2-containing solution for indicated times and residual infectivity was analysed by plaque assay. The pristine PIL nanoparticles coated on the glass substrate have little-to-no virucidal effect on SARS-CoV-2 virions in the first 60 min compared to uncoated glass. By contrast, the plot of virucidal activity of the composite of PIL/Cu nanoparticles indicates that within 30 min, 90% of SARS-CoV-2 virions is deactivated, and 180 min is enough for 99.5% deactivation.
- the introduced Cu nanoparticles play a decisive role in the antivirus function here.
- Copper nanoparticles have been a favorable choice as protective coating due to their known virucidal function.
- the film coating sticks to the surface, unlike the majority of ethanol-based liquid disinfectants that need to be repeatedly used to eliminate virus from surfaces.
- the colloidal dispersion of PIL/Cu composite nanoparticles is more effective in long-term protection of surfaces against SARS-CoV-2 virions and helping reduce their spread through surface contact.
- the inventors have practiced the preparation of a composite film containing imidazolium-based PIL nanoparticles with a dodecyl substituent and the Cu nanoparticles located on them.
- the unique quasi-sphere multilamellar structure of PIL nanoparticles enables the water-insoluble PIL to be well-dispersed in water in the form of nanoparticles.
- the PIL nanoparticles can effectively stabilize Cu nanoparticles on their surface.
- the waterborne composite nanoparticles can spray onto and coat the substrate surface.
- the virucidal activity test proves such surface coatings have potential application to deactivate SARS-CoV-2 virions from surfaces.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Dentistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Paints Or Removers (AREA)
Abstract
The disclosure relates to a colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating, comprising a composite of: (a) a poly(ionic liquid) particle comprising a n-alkyl substituent in the repeating unit; and (b) metal nanoparticles that are deposited on the poly(ionic liquid) particles; wherein the composite particle is in a polar protic solvent, such as water-based solution. The disclosure further relates to a coating composition for antimicrobial and virucidal surface coating, a method for applying the coating composition, and a method for preparation of a colloidal composite particle dispersion.
Description
A COLLOIDAL COMPOSITE PARTICLE DISPERSION FOR USE IN AN ANTIMICROBIAL AND
VIRUCIDAL SURFACE COATING
Technical field
The present disclosure relates to a colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating, a coating composition for antimicrobial and virucidal surface coating, a method for applying the coating composition, uses of the colloidal composite particle dispersion and/or the coating composition, and a method for preparation of a colloidal composite particle dispersion as defined in the independent claims.
Background art
World Health Organization (WHO) declared in March 2020 a pandemic and a global crisis caused by a new coronavirus, SARS-CoV-2 (COVID-19) that was discovered to be the cause of a rapidly spreading outbreak of respiratory disease. By November 2020, more than 50 million infection cases and 1 million deaths have been confirmed.
Coronaviruses are so named because of their characteristic solar corona (crown-like) appearance when observed under an electron microscope. The SARS-CoV-2 virion is spherical with an average size of 78 nm. SARS-CoV-2 is a delicate but highly contagious virus capable of spreading primarily from person to person around the world. It can also spread when an infected person coughs or sneezes and a droplet lands on a surface or object, which is touched by a person and then the person's nose, mouth or eyes. On a personal level, hygiene measures are recommended to prevent the spread of disease, especially in areas where individuals might be in contact with patients or contaminated fomites. Washing hands with soap and water or with alcohol-based hand rubs are effective for interrupting virus transmission.
Though coronaviruses are relatively easy to destroy by using disinfectants like ethanol (62- 71%), or hydrogen peroxide (0.5%) by breaking their delicate envelope that surrounds the tiny microbe, recent studies show SARS-CoV-2 can remain viable or infectious on various surfaces for several hours to days if without any disinfectants. Ethanol-based disinfectants
are so far the most widely used due to the easy access to ethanol, but the drawback is the quick evaporation of ethanol so a surface stays clean only upon repeated treatment of ethanol-based disinfectants.
Scientists and industry companies have realized that Cu- or Ag-coated surface can sanitize by itself by neutralizing the contaminated coronavirus quickly, thus eliminating the possibilities of its transfer to the human body and its subsequent spreads
EP-A-3462526 discloses a biomedically active material, comprising atomically dispersed metal species on the surface of a carbon material. The metal species are dispersed in an ionic liquid. The carbon atoms have a sp2 hybridization. The intended use is for example as a coating in an electrode for oxidation.
US2020239709A1 discloses a composite resin comprising silver nanoparticles and a polymer. The silver nanoparticles are formed by reduction of silver ions. The resin can be used e.g. as an antimicrobial surface coating.
KR101465866B1 discloses polymer-silver nanoparticles including 2-(2-acetoxy) ethyl methacrylate and silver. The nanoparticles can be used for antibiosis activity, as a coating material.
Charan et al. (European Polymer Journal, Vol 60, Nov 2014, p 114-122 (ISSN 0014-3057)) discloses poly(ionic liquids) as "smart" stabilizers for metal nanoparticles. Surface coating by use of Cu or Ag nanoparticles assisted by a polymer matrix are used to prevent the spread of coronavirus. However, most studies and commercial products aim to target surfaces exposed to air. Either the production of such composite film is conducted in non-aqueous solution or their surface coating films are unstable in aqueous condition (the polymer matrix is soluble in water).
Thus, antimicrobial surface coatings comprising metal ions (such as silver) bound by a polymer are known. However, such coatings have limited utility, e.g. under wet conditions. Further, the production process of such coatings typically require the use of multiple chemicals/solvents that are hazardous and/or environmentally challenging. There is thus a need for improved surface coatings for these purposes.
Summary
It is an object of the present disclosure to mitigate, alleviate or eliminate one or more of the above-identified deficiencies and disadvantages in the prior art and solve at least the above mentioned problems. More specifically, it is an object of the invention to provide a waterborne material providing an antimicrobial and virucidal activity, and that can be used for a broader range of surface coatings, e.g. both outdoor and indoor, thereby requiring wetstable properties.
According to a first aspect there is provided a colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating, comprising a composite of: (a) a colloidal poly(ionic liquid) particle that is molecularly insoluble in water and comprises a n-alkyl substituent; and (b) metal nanoparticles that are deposited on the poly(ionic liquid) particles; wherein the composite particle is in a polar protic solvent, such as a water-based solution.
Thus, by using poly(ionic liquid) particles with an alkyl chain substituent (typically a long alkyl chain) in each repeating unit, as carrier of metal species to produce the colloidal poly(ionic liq uid)/meta I composite particles in polar protic media, such as water-based solution, such colloidal dispersion can be sprayed onto various surfaces to kill occurring microbes and viruses, such as COVID 19. As the used poly( ion ic liquid) polymers are not soluble in water (though their particles are waterborne and can be dispersed in water), the formed composite films are stable in both dry and wet condition, e.g. for outdoor surface coating.
According to some embodiments, the cation of the polymer particle is chosen from imidazolium, triazolium, tetraalkylammonium and tetraalkylphosphonium.
These cations have proven to be especially suitable for the purposes of the invention, because these cationic polymer particles can be easily prepared by free radical polymerization in an aqueous environment.
According to some embodiments, the n-alkyl substituent is chosen from the interval of octyl to octadecyl substituent, because these long alkyl chains make the polymer insoluble in water-based solution. In some embodiments, the n-alkyl substituent is chosen from the interval of dodecyl (C12) to tetradecyl (C14) substituent.
According to some embodiments, the metal nanoparticle is chosen from Cu or Ag. In some embodiments the metal nanoparticle is chosen from Cu. These metals have proven to be especially effective for antimicrobial and/or virucidal applications. According to some embodiments, the polar protic solvent is an aqueous media, where the water content is above 50%. Hereby, the spray-coating for protective surfaces against microbes or viruses, such as COVID-19, is fully water-based, and can easily be used to protect surfaces also in both dry and wet condition, as well as it is environmentally friendly.
According to a second aspect there is provided a coating composition for antimicrobial and virucidal surface coating, comprising the colloidal particle dispersion according to any of the embodiments of the first aspect, and optionally additional ingredients such as dye and/or odorant molecule(s), odor control chemical(s), to change color and/or smell, stabilizer(s), surfactant(s) and/or pH modifier(s),, wherein the coating composition exhibits water stability.
According to some embodiments, hydrophobic fluorescent molecules are included in the composition to improve visibility of the coating surface.
According to a third aspect there is provided a method for applying the coating composition.
According to some embodiments, the coating composition is for use in spray applications. Hereby, the coating composition is easily applied to suitable surfaces, for which it is desirable to achieve an antimicrobial and/or virucidal activity, thereby limiting or eliminating the risk of e.g. virus spreading and/or contamination.
According to some embodiments, the coating composition is applied as a film having a thickness in the interval of 10-500 pm, for indoor and/or outdoor applications. Such film can e.g. be used to cover various devices, machines and products in order to limit and/or inactivate the spreading of microbes and/or viruses.
According to a fourth aspect, use of the colloidal composite particle dispersion and/or the coating composition in virucidal applications, such as for deactivation or elimination of COVID 19 at a suitable indoor and/or outdoor surface, is provided.
According to a fifth aspect there is a method provided for preparation of a colloidal nanoparticle dispersion, comprising the steps of:
(a) providing a -ionic liquid monomer with a n-alkyl substituent, wherein n is in the interval from 8 to 18;
(b) polymerizing the n ionic liquid monomer with a n-alkyl substituent in a polar protic solvent, such as a water-based solution, in the presence of a radical initiator to produce a colloidal poly(n-alkyl-ionic liquid) particle dispersion;
(c) adding a metal salt to the dispersion of step (b), and
(d) reducing the metal salt by adding a reducing agent to the dispersion of step (c) thereby obtaining a colloidal poly(ionic liquid)/metal composite particle dispersion.
Hereby, a method for preparing a dispersion for use in antimicrobial and/or virucidal coatings is provided.
In some embodiments, the n-alkyl chain-ionic liquid monomer provided in step (a) is in a concentration of about 0.5-20% (weight).
In some embodiments, the reducing agent of step (d) is added in a 2 molar equivalent ratio to the metal salt to ensure full reduction of metal salts to metal nanoparticles.
Thus, the solution according to the invention is to use poly( ion ic liquid) particles with long alkyl substituent in the repeating unit as carrier of metal (preferably Ag or Cu) species to produce the colloidal poly(ionic liquid)/metal composite particles in polar protic solvent media (preferably aqueous media). Such colloidal dispersion can be sprayed onto various surface to kill microbes and/or viruses, such as SARS-CoV-2. As the used poly(ionic liquid) polymers are not soluble in water (though their particles can be dispersed in water), the formed composite films are stable in both dry and wet condition, e.g. for outdoor surface coating. Also, the invention provides such material in an environmentally friendly way. Such spray liquids can be produced in water as a green solvent and after spray-coating the poly(ionic liquid)/metal colloidal composite particles can resist wet conditions, so that they can be used both indoor and outdoor.
Effects and features of the second, third, fourth and fifth aspects are to a large extent analogous to those described above in connection with the first aspect. Embodiments mentioned in relation to the first aspect are largely compatible with the other aspects.
The present disclosure will become apparent from the detailed description given below. The detailed description and specific examples disclose preferred embodiments of the disclosure by way of illustration only. Those skilled in the art understand from guidance in the detailed description that changes and modifications may be made within the scope of the disclosure.
Hence, it is to be understood that the herein disclosed disclosure is not limited to the particular features of the dispersion or the coating composition described or steps of the methods described since such products and method may vary. It is also to be understood that the terminology used herein is for purpose of describing particular embodiments only, and is not intended to be limiting. It should be noted that, as used in the specification and the appended claim, the articles "a", "an", "the", and "said" are intended to mean that there are one or more of the elements unless the context explicitly dictates otherwise. Thus, for example, reference to "a unit" or "the unit" may include several devices, and the like.
Furthermore, the words "comprising", "including", "containing" and similar wordings do not exclude other elements or steps.
Brief descriptions of the drawings
The above objects, as well as additional objects, features and advantages of the present disclosure, will be more fully appreciated by reference to the following illustrative and nonlimiting detailed description of example embodiments of the present disclosure, when taken in conjunction with the accompanying drawings and Examples.
Figure 1 shows a cryogenic transmission electron microscopy (cryo-TEM) image of the poly(l-n-dodecyl-3-vinylimidazolium bromide) particles. The size is around 20-50 nm.
Figure 2 shows a cryo-TEM image of the poly(ionic liquid)/Cu colloidal composite particles. Cu nanoparticles are located onto the poly(ionic liquid) particles. The Cu nanoparticles are around 1-4 nm (highlighted by white arrows; the PIL particles are 20- 50 nm in size).
Figure 3 shows the virucidal activity of surfaces coated with pristine PIL, and a PIL/Cu particle composite.
Figure 4 schematically illustrates the process of deactivation of SARS-CoV-2 virions by the formed surface coating by PIL/copper composite nanoparticles. Figure 5 discloses a 1H-NMR spectra of poly(3-dodecyl-l-vinylimdiazolium bromide) in CDCh.
Figure 6 discloses a TGA plot of PIL nanoparticles under air from room temperature to 900 °C
Figure 7 discloses a schematic representation of the surface spray coating of a glass substrate by an aqueous colloidal dispersion of PIL/Cu composite particles.
Figure 8 (A, B) discloses cryo-TEM images of the pristine PIL nanoparticles dispersed in aqueous solution.
Figure 9: A) SEM image of the PIL/Cu composite nanoparticles on a glass substrate, B) Cryo- TEM image of PIL/Cu nanoparticles dispersed in aqueous media. C) XRD patterns of PIL and the PIL/Cu composite nanoparticles, D) TGA curve of the PIL/Cu composite nanoparticles under air from room temperature to 900 °C. Figure 10 (A, B) discloses water contact angle measurements of glass substrates coated with PIL nanoparticles, and the PIL/Cu composite nanoparticles, respectively. C) Characterization of antiviral activity of glass slides coated with PIL nanoparticles and the composite of the PIL/Cu nanoparticles against SARS-CoV-2 virions at various times.
Definitions
The term "a colloidal dispersion" is to be interpreted as a mixture that has particles ranging between 15 nm and 1 mm in diameter, and are essentially evenly distributed throughout the solution. The term "a colloidal composite particle dispersion" is to be interpreted as a mixture that has particles with combination of two or more materials with different physical and chemical properties ranging between 1 nm and 1 mm in diameter, and are essentially evenly distributed throughout the solution.
The term "composite" is to be interpreted as a combination of two or more materials with different physical and chemical properties.
The term "antimicrobial" is to be interpreted as an agent that kills microorganisms or stops their growth.
The term "virucidal" is to be interpreted as an agent having the capacity to or tending to destroy or inactivate viruses
The term "poly(ionic) liquid" is to be interpreted as a group of charged polymers that are produced by the polymerization of ionic liquids or by covalent attachment of ionic liquids into the repeating unit of polymers.
The term "nanoparticle" is to be interpreted as particles with their size in the range of 1 to 100 nm.
The meaning of the term "polar protic solvent" is in the context of this invention referred to the following reference:
The term "water-based solution" is to be interpreted as either pure water or a mixture in which water is more than 50% in volume.
The term "water stability" is to be interpreted as the microstructures of the composite film do not change in contact with water.
The term "solubility in water" is to be interpreted as the ability of a solute to molecularly dissolve in water as a solvent.
The term "suitable surface" is to be interpreted as a surface of indoor and/or outdoor type and/or conditions, to which the coating composition and/or the colloidal composite particle disperson can be applied, thereby providing the desired antimicrobial and virucidal effects.
Detailed description
The present disclosure will now be described with reference to the following detailed disclosure of aspects and embodiments, as well as according to the accompanying examples and drawings, in which preferred example embodiments of the disclosure are shown. The disclosure may, however, be embodied in other forms and should not be construed as limited to the herein disclosed embodiments. The disclosed embodiments are provided to fully convey the scope of the disclosure to the skilled person.
The first aspect of this disclosure shows a colloidal particle dispersion of 0.01 to 50 % in concentration (weight), preferably of 0.1-10 % (weight) for use in an antimicrobial and virucidal surface coating, comprising a composite of: (a) a poly(ionic liquid) particle comprising a n-alkyl substituent in each repeating unit; and (b) metal nanoparticles that are deposited on the poly(ionic liquid) particles; wherein the composite particle is in a polar protic solvent, such as a water-based solution.
The poly(ionic liquid) ("PIL") particles typically have a size in the interval of 15 nm to 1mm, preferably 15 nm to 100 pm, more preferably 15 nm to 10 pm, and most preferably 20 nm to 1 pm. The polymer particles of the invention are typically not molecularly soluble in water. Instead they are dispersible in water.
The solid content of the colloidal particle dispersion is typically in the interval from 0.01 - 50 % (weight), preferably 1-10 % (weight). Poly(ionic liquid) is therefore present in an interval from 0.01 - 50 % (weight), preferably in the interval from 0.1 to 10 % (weight), and more preferably from 1 to 5% (weight). Metal nanoparticles are deposited on the poly(ionic liquid) particles at a content in the interval from 0.01-50 wt%, preferably in the interval from 0.1- 20 wt%, and most preferably in the interval from 1-15 wt%,.
Typical conditions for the surface coating to be efficient are e.g. a temperature in the interval of 0-100 °C, preferably 10-60 °C, more preferably 15-35 °C, and most preferably around room temperature, such as about 20-25 °C. The air moisture can e.g. be up to about 95% relative humidity.
The main mechanism for the coating to be efficient for viruses and microbials works by the release of either Cu2+ ions or Ag+ ions to kill virus or microbes. The surface coating of the present invention is active against many different microbes Campylobacter, Clostridium perfringens, E. coli, listeria, salmonella, bacillus cereus, botulism, and shigella and viruses such as SARS-CoV-2, norovirus, and hepatitis A virus..
In some embodiments the cation of the poly(ionic liquid) particle is chosen from imidazolium, triazolium, tetraalkylammonium and tetraalkylphosphonium, wherein the most preferred cation is imidazolium because it is the most widely reported one in literature and the most widely used in our society.
In some embodiments the n-alkyl substituent is chosen from the interval of octyl C8 to octadecyl C18 substituent. Most preferred are the C12 and C14 substituents, because the monomers with C12 and C14 alkyl substituents can produce stable poly(ionic liquid) particles at high concentrations above 10 wt%.
In some embodiments the metal nanoparticle is chosen from Cu or Ag, especially Cu.
The polar protic solvent is typically an aqueous media, but for some applications the polar protic solvent may also be chosen from e.g. ethanol, isopropanol, ethyl glycol and triethyl glycol.
The second aspect of this disclosure shows a coating composition for antimicrobial and/or virucidal surface coating, comprising the colloidal particle dispersion according to the first aspect, and optionally additional ingredients such as dye and/or odorant molecule(s), odor control chemical(s), in order to change color and/or smell, stabilizer(s), surfactant(s) and/or pH modifier(s), wherein the coating composition exhibits water stability. Hydrophobic fluorescent molecules, e.g. carotene and Nile red, can be added to or included in the composition to improve the visibility of the coating surface. These dye molecules are stored in the poly(ionic liquid) particles due to their hydrophobic interaction in the aqueous dispersion. For coating compositions, the dispersion typically has a concentration in the interval of 0.1-50 % (weight), depending on the application and the desired properties of the coating. The dispersion in a low concentration (below 15%) is preferred for coating of a surface with thickness less than 100 micron meters, while the dispersion in a high concentration (above 15%) is favoured for coating of a surface with thickness more than 100 micron meters. Typically, no other ingredients than the dispersion of the present invention are necessary for obtaining the coating composition. In such cases, the dispersion of the first aspect of the invention can be used as the coating composition, and hence the embodiments and features related to the coating composition will be fully applicable to the dispersion of the invention as such.
Typically, the coating composition of the present invention can be stored under the following conditions: temperature: 2-100 °C under normal pressure, i.e. so that the water phase is prevented from freezing as well as boiling. The composition can be stored for a long time, such as months, or even up to about 2 years or more.
The coating composition can be used in several types of applications and/or methods (also referred to as a third aspect), as long as the overall objective is met, i.e. to provide an antimicrobial and/or virucidal coating on a relevant type of surface (i.e. a target surface). For example, the dispersion of the invention may be used in spray applications. Such spray contains the polymer/metal composite colloidal particles typically in the concentration of 0.5 to 5 % (weight). Preferably, the metal is Ag or Cu, especially Cu. The dispersion can easily be sprayed onto the target surface to be protected. In order to obtain full effect, the surfaces should be fully covered by the coating, i.e. spray should be applied so that the entire target surface is covered and protected, thereby limiting or eliminating the occurrence of microbial and/or viral particles adhering to and being able to survive, grow and/or spread, e.g. so that viruses are prevented from contaminating a surface and spreading to humans and/or animals.
Other specific features of the coating composition of the invention and its application and use:
• Typical thickness: 5-500 micrometers, even though any thickness outside this interval may also be formed in accordance with the invention.
• Size of surface to be covered by the coating/film: The coating can be applied to any surface size, as long as it is practically possible, i.e. that the spray coating machine used or any other device used for applying the material, is adapted to apply the surface size. Hence, using a spray coating machine as disclosed in Example 5, a surface size of 10 cm x 10 cm can be applied. For larger surfaces to be coated, such as tables or the like, having sizes like several squaremetres, or smaller surfaces, a spray coating machine or device having properties adapted for such surface sizes can be used. The skilled persons would be able to understand and adapt the device(s) used for the specific application, e.g. by using and/or adapting spray application devices typically used for other purposes, such as typical spray bottles for personal use and/or spray machines used in automotive industry or in paint applications.
• The coating may be applied to most surfaces. In some cases where the surface energy is very low, such as the surface of fluorinated or perfluoronated plastics, e.g. Teflon, a primer may preferably be applied before applying the coating, to increase the binding strength of the coating to the surface.
In a further aspect, the coating composition and/or the colloidal composite particle dispersion is used in virucidal applications, such as for deactivation or elimination of SARS- CoV-2 from a surface.
Further, in some embodiments, the composite material of the invention, e.g. in the form of a film, can be used in applications such as air circulation machines to deactivate any SARS- CoV-2 in the indoor air. Such rooms can e.g. be living houses, working areas, trains, and planes or other transport means.
The film comprising the composite material of the invention, can for example be formed as disclosed in detail in Example 5 using a spray coating machine. Typically, such film has thickness of 5 to 500 micron meters, depending on the solid content of the dispersion. Thus, dispersion having a high solid content will typically be used for formation of a film having a relatively higher thickness, and a dispersion having a low solid content will typically be used for formation of a film having a relatively lower thickness.
The fifth aspect of this disclosure shows a method for preparation of a colloidal particle dispersion according to the first aspect, comprising: (a) providing an ionic liquid monomer with a n-alkyl substituent, wherein n is in the interval from 8 to 18; (b) polymerizing the n- alkyl chain ionic liquid monomer in a polar protic solvent such as water-based solution by adding a radical initiator, initiating the polymerization to produce a colloidal poly(n-a I kyl- ionic liquid) particle dispersion; (c) adding a metal salt to the dispersion of step (b), and (d) reducing the metal salt by adding a reducing agent to the dispersion of step (c) to obtain a colloidal poly(ionic liquid)/metal composite particle dispersion.
The n-alkyl chain-ionic liquid monomer is typically provided in step (a) in a concentration of about 0.5 -20 % (weight). The ionic liquid monomer is typically synthesized (see Example 2).
In step (b), the water-soluble radical initiator (e.g. V-501, V-50, VA-044, and VA-086) is typically added at a concentration of about 0.5-3 % (weight) of the n-alkyl chain-ionic liquid monomer. The water-soluble initiator can easily be purchased. The skilled person would know how to obtain the initiator. The metal salt, typically a Cu or Ag salt chosen from the list of CuCb, CuBr?, CufOAc /AgOAc, CnfNOsh/AgNC , copper/silver acetylacetonate, and copper/silver phosphate, is typically added in step (c) at 0.1 to 50 % (weight) of the polymer nanoparticles, preferably about 1 to 10 % (weight) of the nanoparticles.
The reduction of step (d) can be performed in several different ways, as long as the necessary reduction is obtained. For example, the metal salt can be reduced by adding a reducing agent to the dispersion of step (b) to obtain the final desired composite dispersion. In a preferred embodiment the reducing agent is added in a 2 molar equivalent ratio to the metal salts to ensure the full reduction of metal salts to metal nanoparticles. The reducing agent can for example be chosen from sodium borhydride (preferably used at room temperature), vitamin C, citric acid, polyols or hydrazine (N2H4) (preferably used at 80 °C or above). When using a silver salt, sodium borhydride is typically used as reducing agent. Depending on the choice of reducing agent, water-soluble by-products may occur after step (d). An additional method step comprising dip-washing the product of step (d) may be introduced to remove such by-products.
Typically, suitable conditions for the preparation of the composite dispersion of the invention are the following:
• Temperature: the polymerization (step (b)) is typically performed in the interval from 50-90 °C, preferably about 70 °C. The reduction (step (d)) is typically performed at a temperature suitable for the chosen reducing agent (reductant), and may vary from about room temperature (15-25 °C) to about 80-100 °C, whatever is suitable for the reducing agent, and as long as the water-based dispersion does not freeze or boil.
• Duration: the polymerization reaction (step (b)) should typically last for about 12 hours, or as long that is necessary for completion. By using TEM and cryo-TEM, completion of the desired reactions and the obtained structures can be shown.
The invention will now be further explained by the following examples, showing exemplary embodiments of the invention, but should not be construed as limiting the scope of the invention.
EXAMPLES
Example 1
In accordance with the present invention, the inventors produced poly(ionic liquid) nanoparticles from a long alkyl chain-ionic liquid monomer, 3-n-alkyl-l-vinylimidazolium
bromide in water. This polymerization forms a stable poly(ionic liquid) nanoparticle dispersion in water, although the poly(ionic liquid) itself is molecularly insoluble thus aggregates into nanoparticles that are dispersed in water.
Without purification, Cu salts, such as copper acetate, copper chloride or cooper acetylacetonate, was added into this solution, followed by addition of a reductant e.g. hydrazine (N2H4) at 80 °C to reduce the Cu salts into Cu nanoparticles, and these Cu nanoparticles are located on the surface of poly(ionic liquid) nanoparticles (Cu nanoparticles are typically 1-4 nm in size, and polymer nanoparticles are typically 15-50 nm in size).
This step forms a stable poly(ionic liquid)/Cu colloidal composite particle dispersion. By spray-coating this dispersion onto a glass plate followed by a dip-washing (30 s) in water, the inventor then tested its virucidal activity towards COVID 19 in Karolinska Institute. Within 3 hours, 99.5% SARS-CoV-2 was deactivated in this test condition.
An example of using poly(3-n-dodecyl-3-vinylimidayolium bromide)/Cu colloidal composite nanoparticles for spray-coating to form an anti- SARS-CoV-2 surface is shown here.
Example 2 - Synthesis of the ionic liquid monomer with C-12 alkyl substituent
9.4 g of 1-vinylimidazole and 25g of bromododecane (1:1 molar ratio) and 20ml of ethanol were mixed together inside 100ml round bottom flask at 40 °C for 16 hrs. A needle was used to reduce the pressure inside the flask. In the next day, the reaction mixture was added drop by drop to IL diethyl ether and the precipitate was filtered off gently, and dried at 40 °C using vacuum oven.
Example 3 - Polymerization of C12 PIL-NP
5g of monomer and 150 mg of a water-soluble thermal initiator VA-086 were added to 100 ml of water inside a 250ml round bottom Schlenk flask. The flask was treated with three freeze-pump-thaw cycles. The reaction was stirred at 70°C for 16 hrs. Next day, the polymer solution was filtered off using a filter paper and a funnel to remove impurities and big
aggregation of nanoparticles. Figure 1 shows a cryogenic transmission electron microscopy (cryo-TEM) image of the synthesized poly(ionic liquid) nanoparticles.
Example 4 - Preparation of C12-Cu NP solution
2ml of C12 PIL-NP solution was diluted with 9ml of water. Then 1ml water containing 10 mg of copper acetate salt was added to the solution. After 30 min, either 5 mg of sodium borhydride in 5 ml of water, or 50 mg of vitamin C, or 0.2 ml of aqueous hydrazine solution (80 wt%) was added to the solution. Very gentle change of color happened during this step. The solution was sonicated for ca. 20 min. Then, in case vitamin C or hydrazine was used as reductants, the solution was placed in an oil bath under stirring at 80°C for overnight. The next day, the color of the solution changed to pink . Next, the solution was sonicated again for ca. 20 min. In the following, by using a 5 pm filter and a syringe the solution was filtered off to remove any big aggregations of Cu-NPs. Figure 2 is a cryo-TEM image of the poly(ionic liquid)/Cu colloidal composite nanoparticles.
Example 5 - Coating procedure
A glass slip with size of 24x24 mm and thickness of 0.5mm was treated with an oxygen Plasma instrument to make the substrate surface hydrophilic and clean for 3 min. At the final stage, with help of a spray coating machine (a spray machine with pore size of 100 micron meters, a flow rate of 2 ml per min, and a point size of 6.5 cm x 6.5 cm at a distance of 8.5 cm), the hydrophilic surface of glass slip was coated with C12-Cu Np dispersion for ca. 30 seconds with a film thickness of 5 to 500 micron meters, depending on the solid content of the dispersion and the spray time.
Example 6 - Antiviral activity tests of hybrid coating
Cover glasses were placed into a 6-well plate and 10 pL containing a known number of infectious units of SARS-CoV-2 was applied in the center of the glass. The droplet was immediately covered by uncoated cover glass to spread the virus on the whole area.
After incubation at specified time, usually 5, 30, and 180 min, 490 pL IX PBS was added to the coverslips, the top coverslip was lifted and the virus-exposed sides of both coverslips were washed with PBS by pipetting 3 times to collect the virus species. The inventors collected the whole washing and used for titer determination. The outcome in Figure 3 shows that within 30 min, 90% of SARS-CoV-2 is deactivated, and 180 min for 99.5% deactivation.
Example 7 - Colloidal dispersion of poly(ionic liquid)/Cu composite particles for protective surface coating against SAR-CoV-2 Herein, the inventors report a waterproof anti-SARS-CoV-2 protective film prepared by spray-coating of an aqueous colloidal dispersion of poly(ionic liquid) /copper (PIL/Cu) composite nanoparticles onto a substrate. The PIL dispersion was prepared by suspension polymerization of 3-dodecyl-l-vinylimdiazolium bromide in water at 70 °C. The copper acetate salt was added into the PIL nanoparticle dispersion and in-situ reduced into copper nanoparticles anchoring onto the PIL nanoparticles. Despite being waterborne, the PIL in bulk is intrinsically insoluble in water and the formed coating is stable in water. The formed surface coating by PIL/copper composite nanoparticles was able to deactivate SARS-CoV-2 virions by 90.0% in 30 min and thus may effectively prevent the spread of SARS-CoV-2 through surface contact (see figure 4). This method may provide waterborne dispersions for a broad range of antivirus protective surface coatings for both outdoor and indoor applications.
The emergence of a current pandemic, caused by a novel coronavirus, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has brought a rapid viral infection over 200+ countries and more than three million deaths globally by the time of this report. The transmission from infected to healthy persons can be transferred through cough, respiratory droplets, biofluids or close contacts. These respiratory pathogens can remain infectious on insentient surfaces for hours to two-three days
Consequently, the determination of antiviral coating materials with high antiviral activity and broad applicability on various surfaces may eliminate the possible infection transfers and reduce the speed of virus spread [3-5]
Metal nanoparticles historically have been proven to show a wide range of virucidal and bactericidal activities due to their effectiveness at a low dosage, small size, high surface area, and acting as ion reservoirs to control the release of bioactive ions. Metal nanoparticles demonstrate the capability to generate reactive oxygen species to destroy the virus and attach to DNA or RNA, and accordingly they can prevent the replication of microorganisms. Since past decades, various types of metal nanoparticles, such as silver (Ag), copper (Cu), iron, iron oxide, gold, and titanium oxide, with antibacterial and virucidal activity have been described vastly in literatures. Among those, Ag nanoparticles are the most widely explored in the literature because of their high effectivity versus infections and high demands in industrial applications. Regardless of multitude benefits of Ag nanoparticles, Cu nanoparticles with high antimicrobial (especially antifungal), low cost and wide availability and abundance can be alternatively utilized [6-12]. If not surface-protected, a rapid aggregation of a dispersion of native metal nanoparticles can cause a large decrease in their reactivity. A common method to overcome this problem is to stabilize metal nanoparticles with organic compounds, such as low molecular weight ligands and chelating polymers by selective functionalization of their surface I13-17].
Poly(ionic liquidjs (PILs) as a subclass of polyelectrolytes are polymer materials with adjustable physiochemical characteristics due to covalently incorporated ionic liquid-like ion pairs in the polymer chains, and usually possess mechanical stability, durability, ion conductivity and multifunctionality I18-19]. This unique combination broadens the application scope of PILs in comparison to conventional polyelectrolytes in versatile research areas such as biosensors I20-21!, biomaterials I22-26], energy materials I27-30], just to name a few. Besides, the self-assembly of PILs has provided new aspects in the direction of functional nanomaterials I31-34]. Thus, it is the inventor's opinion that well-defined self-assembled PIL nanoparticles can be promising candidates to support and stabilize metal nanoparticles to maintain metal's antiviral and antibacterial activity I35-36!. Previously the inventor group investigated straightforward self-assembly of imidazolium and triazolium-based PIL nanoparticles with different alkyl chain lengths and tunable structures. These PILs due to the presence of long alkyl chain can self-assemble into multi and unilamellar vesicles, or wasp- like dispersible nanoparticles when they are produced in water [37-39] although these PILs in bulk are water-insoluble.
In this contribution, the inventors investigated the potential anti-SARS-CoV-2 activity of a composite film consisting of spray-coated PIL/Cu nanoparticles from their aqueous colloidal dispersion. Detailed materials characterization certified the establishment of smaller Cu nanoparticles onto the PIL nanoparticles. The inventor's virucidal activity tests show high virucidal activities of such films against SARS-CoV-2 virions, pointing out potential applications of such spray-coatings for indoor and outdoor surfaces to decline the infection and transmission of SARS-CoV-2 virions via contaminated surfaces.
1. Experimental
1.1 Chemicals 1-Vinylimidazole (99%) and copper (II) acetate monohydrate were purchased from Alfa Aesar. 1-Bromododecane was purchased from Acros Organic. 2,2'-Azobis[2-methyl-N-(2- hydroxyethyl)propionamide] (VA-086) was purchased from FUJIFILM Wako Chemicals. L- ascorbic acid and hydrazine hydrate 35 % solution in water were purchased from Sigma- Aldrich. All chemicals were used without any further purification. Solvents were of analytical grade.
1.2 Instruments
Nuclear magnetic resonance (NMR): 1H-NMR spectra were recorded at room temperature using a Bruker DPX-400 spectrometer operating at 400 MHz. CDChwas used as a solvent for the measurement. Scanning electron microscopy (SEM): The morphology of the samples was recorded on a JEOL 7000 operated at 3 kV. Samples were coated with a thin gold layer for 40 seconds before examination.
Transmission electron microscopy (TEM): The morphology of the nanoparticles was measured using a JEOL JEM-2100 transmission electron microscope (JEOL GmbH, Eching, Germany) operated at an acceleration voltage of 200 kV. Nanoparticles suspended in water were dried on continuous carbon-coated copper TEM grids (200 mesh, Science Services).
Cryogenic transmission electron microscopy (cryo-TEM): Cryo-EM specimens were prepared by applying a 4 pL drop of a dispersion sample to Lacey carbon-coated copper TEM grids
(200 mesh, Science Services) and plunge-frozen into liquid ethane with an FEI vitrobot Mark IV set at 4 °C and 95% humidity. Vitrified grids were either transferred directly to the microscope cryogenic transfer holder (Gatan 914, Gatan, Munich, Germany) or stored in liquid nitrogen. Imaging was carried out at temperatures around 90 K. The TEM was operated at an acceleration voltage of 200 kV, and a defocus of the objective lens of about 2.5-3 pm was used to increase the contrast. Cryo-EM micrographs were recorded at a number of magnifications with a bottom-mounted 4 x 4 k CMOS camera (TemCam-F416, TVIPS, Gauting, Germany). The total electron dose in each micrograph was kept below 20 e-A-2. X-ray diffraction (XRD): XRD measurements were carried out using a Bruker D8 diffractometer in the locked coupled mode (20 ranging from 10° to 80°) with Cu Kai radiation. The PIL/Cu composite sample was measured with an air-tight XRD holder from Bruker.
Thermal gravimetric analysis (TGA): TGA measurements were performed using a PerkinElmer (TGA 8000) from 25 to 900 °C under a constant argon flow (30 mL min-1) with a heating rate of 10 K min-1.
Contact angle measurement: The contact angle was measured using the image of a sessile drop with DI water at the points of intersection (three-phase contact points) between the drop contour and the projection of the surface (baseline) (KRUSS instruments, DSA25E, CA).
1.3 Synthesis of the ionic liquid monomer (3-dodecyl-l-vinylimdiazolium bromide)
9.4 g of 1-vinylimidazole and 25g of 1-bromododecane (1:1 molar ratio) and 20 ml of ethanol were mixed together inside a 100 ml round bottom flask at 40 °C for 16 h. A needle was used to reduce the pressure inside the flask. In the next day, the reaction mixture was added drop by drop to IL diethyl ether and the precipitate was filtered off gently, and dried at 40 °C using vacuum oven.
1.4 Synthesis of poly(l-n-dodecyl-3-vinylimidazolium bromide) nanoparticle dispersion
5g of monomer and 150 mg of a water-soluble thermal initiator VA-086 were added to 100 ml of water inside a 250ml round bottom Schlenk flask. The flask was treated with three freeze-pump-thaw cycles. The reaction was stirred at 70°C for 16 h. Next day, the polymer dispersion was filtered off using a filter paper and a funnel to remove impurities and big aggregation of nanoparticles. The proton nuclear magnetic resonance (1H-NMR) spectra is shown in Figure SI, where the chemical shifts of all signals are well-assigned to individual protons in polymer.
1.5 Preparation of the PIL/Cu colloidal nanoparticle dispersion 2 ml of the PIL nanoparticle dispersion was diluted with 9 ml of water. Then 1 ml of water containing 40 mg of copper acetate salt was added to the solution. After stirring for 2 h, aqueous hydrazine solution (35 wt.%) was dropwise added to the solution. Very gentle change of color happened during this step. The solution was sonicated for ca. 20 min. Then, the solution was placed in an oil bath under stirring at 80°C for overnight. The next day, the color of the solution changed to pink. Next, the solution was sonicated again for ca. 20 min. In the following, by using a 5 pm filter and a syringe the solution was filtered off to remove any big aggregates.
1.6 Coating procedure A glass slip with size of 24 x 24 mm and thickness of 0.5 mm was treated with an oxygen Plasma instrument for 3 min to make the substrate surface hydrophilic and clean. At the final stage, with help of a spray coating machine (a spray machine with pore size of 100- micron meters, a flow rate of 2 ml per min, and a point size of 6.5 cm x 6.5 cm at a distance of 8.5 cm), the hydrophilic surface of glass slip was coated with the PIL/Cu nanoparticles dispersion for ca. 30 seconds with a film thickness of ca. 100-micron meters. The rinsed film was dried under vacuum (5 x 10-2 mbar) at 80 °C overnight.
1.7 Antiviral activity tests of hybrid coating
Cover glasses were placed into a 6 cm dish and 50 pL containing a known number of infectious units of SARS-CoV-2 was applied in the centre of the glass. The droplet was immediately covered by uncoated cover glass to spread the virus on the whole area. After incubation at specified time, usually 5, 15, 30, 60 and 180 min, 1950 pL IX PBS was added to the coverslips, the top coverslip was lifted and the virus-exposed sides of both coverslips were washed with PBS by pipetting 3 times to collect the virus species. All washes were collected and used for titre determination by plaque assay. Briefly, Vero E6 cells (ATCC-CRL- 1586), maintained in Dulbecco's modified Eagle medium (Gibco) supplemented with 10% fetal calf serum and 1% penicillin-streptomycin and cultured at 37 °C in a humidified incubator with 5% CO2, were washed with PBS, and two-fold serial virus dilutions of SARS- CoV-2 was added in 200 pL minimal essential medium (Invitrogen) supplemented with 0.2% bovine serum albumin, 2 mM L-glutamine, and 20 mM HEPES with periodic shaking for 1 h 37°C. Virus solutions were then removed and cells washed with PBS before addition of 1 mL of prewarmed overlay (2% Methylcellulose: propagation media containing 2% FBS= 2:3). At 48-72 h post infection, cells were fixed with 4% formaldehyde and stained with crystal violet solution after removal of the overlay and plaques were manually quantified. The determination of all virus titres was performed in triplicate.
2. Supplementary Data 2.1 1H-NMR spectrum of PIL
See Figure 5.
2.2 TGA analysis of PIL nanoparticles
See Figure 6.
Results and discussion
The stepwise fabrication of the spray-coating film onto a glass slide with a colloidal dispersion of PIL/Cu composite nanoparticles is provided in Figure 7. The colloidal nanoparticle dispersion comprises a composite of PIL nanoparticles containing Cu
nanoparticles that are located on PIL nanoparticles. The synthesis and characterization details of the PIL used in this study, named poly(l-n-dodecyl-3-vinylimidazolium bromide) are provided in Supporting Information.
The convenient method to obtain Cu nanoparticles in the solution phase is the chemical reduction of a copper salt by a proper reducing agent. Several reducing agents can be utilized at different reaction temperature, e.g. sodium borohydride at room temperature, hydrazine (N2H4, at 80 °C), and ascorbic acid (vitamin C, at 100 °C) I40-42]. Depending on the choice of the reducing agent, water-soluble by-products may be generated after the reduction of copper salt. An additional step of dip-washing of the film product in clean water for 30 s is added to remove any by-product.
In a typical surface coating procedure, copper acetate was added into the aqueous dispersion of PIL nanoparticles. In following, a reductant hydrazine (N2H4) was added at 80 °C to reduce the Cu ions into Cu nanoparticles, which are stabilized in situ by the surface of PIL nanoparticles. To ensure the full reduction of metal salts to metal nanoparticles, the reducing agent was added in a 2 molar equivalent ratio to the metal salt. Next, via a spray setup, the dispersion solution was sprayed onto the surface of a glass slide, which due to the water-insolubility of the PIL forms a waterproof film that remains intact when dipped washed in water. The film on the glass slide was then placed under vacuum (5 x 10-2 mbar) and fully dried in an oven at 80 °C at least for 2 hours. More detailed information about the coating preparation method is provided in Supporting Information.
In Figure 8 A,B, cryogenic transmission electron microscopy (cryo-TEM) images of the PIL nanoparticles with a long dodecyl substituent on the vinylimidazolium repeating unit in aqueous solution are provided. The dark dots represent the PIL nanoparticles in a spherical shape. The native inner morphology is clearly distinguishable, where a quasi-spherical onionlike vesicular nanostructure is identified with its size variation in the range of 20-50 nm. The dark ring within the nanoparticles represents the ionic mainchain domain, and the higher contrast originates from the Br anion that serves also as a contract agent here. The grey ring zones come from the packed alkyl substituents that are of a lower contract in the TEM. The number of bilayers of co. 3.42 nm in thickness is countable in the typical range of 4-8 and is dependent on the size of nanoparticles. Previously, the analysis of small-angle X-ray scattering (SAXS) measurements showed a d spacing of 3.40 nm for PIL nanoparticles with a
dodecyl substituent [39], which is in agreement with the value determined here by the cryo-
TEM tests.
The scanning electron microscopy (SEM) shown in Figure 9A visualizes a composite of PIL/Cu colloidal nanoparticles in a spherical shape with a similar size as the pristine PIL nanoparticles. The sample morphology on the glass substrate does not change after the glass plate was immersed in water for 10 minutes, a phenomenon that arises from the insoluble nature of the PIL nanoparticle in water and its strong surface-binding function. But the presence of Cu nanoparticles cannot be demonstrated by SEM due to their rather small size. Therefore, cryo-TEM for the PIL/Cu colloidal composite was employed (Figure 9B). Clearly, Cu nanoparticles of 1-4 nm in size are observed to locate on PIL nanoparticles, highlighted by white arrows. It is worthwhile to mention that particles smaller than 1 nm may exist but are not observable due to the weak contrast between the PIL matrix and the Cu nanoparticles in the cryo-TEM image. In order to confirm the existence of Cu nanoparticles in the composite dispersion, X-ray diffraction (XRD) patterns of the dried PIL nanoparticles and PIL/Cu composite were recorded and are compared in Figure 9C. The comparison between these two patterns reveals that the PIL nanoparticles are obviously in an amorphous state, and the presence of all three sharp peaks in the XRD pattern of the PIL- Cu composite sample is in accordance with the standard pattern of pure face-center cubic metallic Cu (JCPDS, File No 04-0836); the three peaks at 43°, 55°, and 74° correspond to the (111), (200), and (220) reflections I43-44!. In Figure 9D, the thermogravimetric analysis (TGA) of the PIL/Cu colloidal composite in air shows a 5 wt.% mass loss at 250 °C, and then a rapid decomposition up to 600 °C, followed by a constant mass loss till a final residue of 13.7% at 900 °C. By contrast, the TGA plot of the pristine PIL nanoparticles shows a complete decomposition already at 600 °C (Figure S2). The difference in mass residue between two samples determines a metallic Cu content of 9.6 wt.% in the PIL/Cu composite particles. This is in good agreement with our combustion-based elemental analysis result of 10.1 wt% of Cu in the composite.
To explore the property of the coated surface with the as-prepared dispersion of PIL/Cu colloidal nanoparticles, water contact angle measurements were performed (Figure 10 A,B). The presence of Cu nanoparticles in the composite of PIL/Cu nanoparticles decreases the
contact angle from 83.6° for pristine PIL nanoparticles to 65.4° for the composite, very possibly due to the increased surface hydrophilicity arising from the Cu nanoparticles I45-46!.
The virucidal activity of glass substrates coated with pristine PIL, and the composite of PIL/Cu nanoparticles is shown in Figure 10C. Substrates were incubated with SARS-CoV-2-containing solution for indicated times and residual infectivity was analysed by plaque assay. The pristine PIL nanoparticles coated on the glass substrate have little-to-no virucidal effect on SARS-CoV-2 virions in the first 60 min compared to uncoated glass. By contrast, the plot of virucidal activity of the composite of PIL/Cu nanoparticles indicates that within 30 min, 90% of SARS-CoV-2 virions is deactivated, and 180 min is enough for 99.5% deactivation. Thus, the introduced Cu nanoparticles play a decisive role in the antivirus function here. Copper nanoparticles have been a favorable choice as protective coating due to their known virucidal function. Note that the film coating sticks to the surface, unlike the majority of ethanol-based liquid disinfectants that need to be repeatedly used to eliminate virus from surfaces. In this context, the colloidal dispersion of PIL/Cu composite nanoparticles is more effective in long-term protection of surfaces against SARS-CoV-2 virions and helping reduce their spread through surface contact.
Conclusions
In conclusion, the inventors have practiced the preparation of a composite film containing imidazolium-based PIL nanoparticles with a dodecyl substituent and the Cu nanoparticles located on them. The unique quasi-sphere multilamellar structure of PIL nanoparticles enables the water-insoluble PIL to be well-dispersed in water in the form of nanoparticles. In combination of the cationic charge on the PIL, the PIL nanoparticles can effectively stabilize Cu nanoparticles on their surface. The waterborne composite nanoparticles can spray onto and coat the substrate surface. The virucidal activity test proves such surface coatings have potential application to deactivate SARS-CoV-2 virions from surfaces.
References
[1] P. K. Rai, Z. Usmani, V. K. Thakur, V. K. Gupta, Y. K. Mishra, Curr. Res. Green Sustain. Chem. 2020, 3, 100011.
[2] D. Chakhalian, R. B. Shultz, C. E. Miles, J. Kohn, J. Biomed. Mater. Res. - Part A 2020, 108, 1974.
[3] S. Talebian, G. G. Wallace, A. Schroeder, F. Stellacci, J. Conde, Nat. Nanotechnol. 2020, 15, 618.
[4] Z. Sun, K. (Ken) Ostrikov, Sustain. Mater. Technol. 2020, 25, e00203.
[5] I. Das Jana, P. Kumbhakar, S. Banerjee, C. C. Gowda, N. Kedia, S. K. Kuila, S. Banerjee, N. C. Das, A. K. Das, I. Manna, C. S. Tiwary, A. Mondal, ACS Appl. Nano Mater. 2021, 4, 352.
[6] M. Rai, S. D. Deshmukh, A. P. Ingle, I. R. Gupta, M. Galdiero, S. Galdiero, Crit. Rev. Microbiol. 2016, 42, 46.
[7] K. Maduray, R. Parboosing, Biol. Trace Elem. Res. 2020, doi:10.1007/sl2011-020- 02414-2.
[8] O. Dtugosz, M. Sochocka, M. Ochnik, M. Banach, J. Colloid Interface Sci. 2020, 586, 807.
[9] B. A. Aderibigbe, Molecules 2017, 22, 1370.
[10] M. Vincent, R. E. Duval, P. Hartemann, M. Engels-Deutsch, J. Appl. Microbiol. 2018, 124, 1032.
[11] C. A. P. Bastos, N. Faria, J. Wills, P. Malmberg, N. Scheers, P. Rees, J. J. Powell, NanoImpact 2020, 17, 100192.
[12] A. K. Chatterjee, R. Chakraborty, T. Basu, Nanotechnology 2014, 25, 13501.
[13] M. C. Sportelli, M. Izzi, E. A. Kukushkina, S. I. Hossain, R. A. Picca, N. Ditaranto, N. Cioff, Nanomaterials 2020, 10, 1.
[14] S. Sarkar, E. Guibal, F. Quignard, A. K. SenGupta, J. Nanoparticle Res. 2012, 14.
[15] R. Sardar, J. W. Park, J. S. Shumaker-Parry, Langmuir 2007, 23, 11883.
[16] M. Kramer, N. Perignon, R. Haag, J. D. Marty, R. Thomann, N. L. De Viguerie, C. Mingotaud, Macromolecules 2005, 38, 8308.
[17] R. Vazquez-Munoz, M. J. Arellano-Jimenez, J. L. Lopez-Ribot, BMC Biomed. Eng. 2020, 2, 1.
[18] W. Qian, J. Texter, F. Yan, Chem. Soc. Rev. 2017, 46, 1124.
[19] J. Yuan, M. Antonietti, Polymer (Guild ). 2011, 52, 1469.
[20] S. Ding, Z. Lyu, X. Niu, Y. Zhou, D. Liu, M. Falahati, D. Du, Y. Lin, Biosens. Bioelectron. 2020, 149, 111830.
[21] Y. Yu, C. Yu, T. Yin, S. Ou, X. Sun, X. Wen, L. Zhang, D. Tang, X. Yin, Biosens. Bioelectron. 2017, 87, 278.
[22] L. Kong, M. Zhang, Y. Zhang, W. Zhang, X. Zhou, L. Zhang, X. Wang, Polym. Chem.
2020, 11, 7429.
[23] X. Feng, K. Zhang, P. Chen, X. Sui, M. A. Hempenius, B. Liedberg, G. J. Vancso, Macromol. Rapid Commun. 2016, 37, 1939.
[24] J. Qin, J. Guo, Q. Xu, Z. Zheng, H. Mao, F. Yan, ACS Appl. Mater. Interfaces 2017, 9, 10504.
[25] Y. Men, M. Siebenburger, X. Qiu, M. Antonietti, J. Yuan, J. Mater. Chem. A 2013, 1, 11887.
[26] R. A. Sequeira, N. Singh, M. M. Pereira, N. A. Chudasama, S. Bhattacharya, M. Sharma, D. Mondal, K. Prasad, Int. J. Biol. Macromol. 2018, 120, 378.
[27] Y. Wang, Y. Shao, H. Wang, J. Yuan, Accounts Mater. Res. 2020, 1, 16.
[28] H. Lin, S. Zhang, J. K. Sun, M. Antonietti, J. Yuan, Polymer (Guild/). 2020, 202, 122640.
[29] W. Zhang, S. Wei, Y. Wu, Y. L. Wang, M. Zhang, D. Roy, H. Wang, J. Yuan, Q. Zhao, ACS Nano 2019, 13, 10261.
[30] K. Grygiel, J. S. Lee, K. Sakaushi, M. Antonietti, J. Yuan, ACS Macro Lett. 2015, 4, 1312.
[31] H. He, K. Rahimi, M. Zhong, A. Mourran, D. R. Luebke, H. B. Nulwala, M. Moller, K. Matyjaszewski, Nat. Commun. 2017, 8, 14057.
[32] W. Xu, P. A. Ledin, V. V. Shevchenko, V. V. Tsukruk, ACS Appl. Mater. Interfaces 2015, 7, 12570.
[33] A. W. May, Z. Shi, D. B. Wijayasekara, D. L. Gin, T. S. Bailey, Polym. Chem. 2019, 10,
751.
[34] Y. Gao, Y. Wang, Y. Yan, K. Tang, C. F. Ding, J. Sep. Sci. 2020, 43, 766.
[35] K. Manojkumar, D. Mecerreyes, D. Taton, Y. Gnanou, K. Vijayakrishna, Polym. Chem. 2017, 8, 3497.
[36] K. Manojkumar, A. Sivaramakrishna, K. Vijayakrishna, J. Nanoparticle Res. 2016, 18, 1.
[37] Y. Men, M. Drechsler, J. Yuan, Macromol. Rapid Commun. 2013, 34, 1721.
[38] W. Zhang, Z. Kochovski, Y. Lu, B. V. K. J. Schmidt, M. Antonietti, J. Yuan, ACS Nano 2016, 10, 7731.
[39] J. Yuan, S. Soil, M. Drechsler, A. H. E. Muller, M. Antonietti, J. Am. Chem. Soc. 2011, 133, 17556.
[40] C. N. R. Rao, G. U. Kulkarni, P. J. Thomas, P. P. Edwards, Chem. Soc. Rev. 2000, 29, 1.
[41] M. Banach, J. Pulit-Prociak, 1. Clean. Prod. 2017, 141, 1030.
[42] P. G. Jamkhande, N. W. Ghule, A. H. Barner, M. G. Kalaskar, J. Drug Deliv. Sci. Technol. 2019, 53, 101174.
[43] H. Zhu, C. Zhang, Y. Yin, Nanotechnology 2005, 16, 3079.
[44] N. A. Dhas, C. P. Raj, A. Gedanken, Chem. Mater. 1998, 10, 1446.
[45] J. Zhu, A. Uliana, J. Wang, S. Yuan, J. Li, M. Tian, K. Simoens, A. Volodin, J. Lin, K. Bernaerts, Y. Zhang, B. Van Der Bruggen, J. Mater. Chem. A 2016, 4, 13211.
[46] J. Xu, L. Zhang, X. Gao, H. Bie, Y. Fu, C. Gao, J. Memb. Sci. 2015, 491, 28.
The person skilled in the art realizes that the present disclosure is not limited to the preferred embodiments described above. The person skilled in the art further realizes that modifications and variations are possible within the scope of the appended claims.
Additionally, variations to the disclosed embodiments can be understood and effected by the skilled person in practicing the claimed disclosure, from a study of the drawings, the disclosure, including the examples, and the appended claims.
Claims
1. A colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating, comprising a composite of: (a) a colloidal poly(ionic liquid) particle that is molecularly insoluble in water and comprises a n-alkyl substituent; and (b) metal nanoparticles that are deposited on the poly(ionic liquid) particles; wherein the composite particle is in a polar protic solvent, such as a water-based solution.
2. The colloidal composite particle dispersion according to claim 1, wherein the cation of the colloidal poly(ionic liquid) particle is chosen from imidazolium, pyridinium, triazolium, tetraalkylammonium and tetraalkylphosphonium.
3. The colloidal composite particle dispersion according to claim 1 or 2, wherein the n-alkyl substituent of the colloidal poly(ionic liquid) particles is chosen from the interval of octyl (C8) to octadecyl (C18) substituent.
4. The colloidal composite particle dispersion according to claim 3, wherein the n-alkyl substituent of the colloidal poly(ionic liquid) particles is chosen from the interval of dodecyl (C12) to tetradecyl (C14) substituent.
5. The colloidal composite particle dispersion according to any of claims 1-4, wherein the metal nanoparticle is chosen from Cu or Ag.
6. The colloidal composite particle dispersion according to claim 5, wherein the metal nanoparticle is Cu.
7. The colloidal composite particle dispersion according to any of claims 1-6, wherein the polar protic solvent is an aqueous media, having a water content above 50%.
8. A coating composition for antimicrobial and/or virucidal surface coating, comprising the
28
colloidal composite particle dispersion according to any of claims 1-7, and optionally other ingredients such as dye and/or odorant molecules, wherein the coating composition exhibits water stability.
9. The coating composition according to claim 8, wherein hydrophobic fluorescent molecules are included in the composition.
10. Method for applying the coating composition of claims 8-9, wherein the coating composition is applied to a suitable indoor and/or outdoor surface as a film having a thickness in the interval of 10-500 pm.
11. Method for applying the coating composition of claim 10, wherein the coating compostion is applied as a spray.
12. Use of the colloidal composite particle dispersion of any of claims 1-7 and/or the coating composition of any of claims 8-9, in virucidal applications including deactivation or elimination of viruses, such as SARS-CoV-2, at a suitable indoor and/or outdoor surface.
13. A method for preparation of a colloidal composite particle dispersion according to claims 1-7, comprising the steps of:
(a) providing a ionic liquid monomer comprising a n-alkyl substituent, wherein n is in the interval from 8 to 18;
(b) polymerizing the ionic liquid monomer comprising the n-alkyl substituent in a polar protic solvent, such as a water-based solution, in the presence of a radical initiator, to produce a colloidal poly(n-alkyl-ionic liquid) particle dispersion;
(c) adding a metal salt to the dispersion of step (b), and
(d) reducing the metal salt by adding a reducing agent to the dispersion of step (c); thereby obtaining a colloidal poly(ionic liquid)/metal composite particle dispersion.
14. The method according to claim 13, wherein the n-alkyl chain-ionic liquid monomer is provided in step (a) in a concentration of about 0.5-20% (weight).
15. The method according to any of claims 13 or 14, wherein the reducing agent of step (d) is added in a 2 molar equivalent ratio to the metal salts to ensure full reduction of metal salts to metal nanoparticles.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE2051436-0 | 2020-12-09 | ||
SE2051436A SE544807C2 (en) | 2020-12-09 | 2020-12-09 | A colloidal particle dispersion for use in an antimicrobial and virucidal surface coating |
SE2150557-3 | 2021-04-30 | ||
SE2150557 | 2021-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022124973A1 true WO2022124973A1 (en) | 2022-06-16 |
Family
ID=79024813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2021/051225 WO2022124973A1 (en) | 2020-12-09 | 2021-12-09 | A colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022124973A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101465866B1 (en) | 2013-03-20 | 2014-12-01 | 서울대학교산학협력단 | Nanocomposite of Biocompatible PHEMA derivatives/Ag having antibacterial and antifouling activity |
WO2016049131A1 (en) * | 2014-09-23 | 2016-03-31 | Attostat, Inc. | Antimicrobial compositions and methods |
EP3462526A1 (en) | 2017-09-27 | 2019-04-03 | Fritz-Haber-Institut Der Max-Planck-Gesellschaft | Atomically dispersed metal species in an ionic liquid on the surface of a carbon material having sp2 hybridization, and method for the preparation thereof |
US20200239709A1 (en) | 2017-05-12 | 2020-07-30 | Inhibit Coatings Limited | Composite resins containing silver nanoparticles |
-
2021
- 2021-12-09 WO PCT/SE2021/051225 patent/WO2022124973A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101465866B1 (en) | 2013-03-20 | 2014-12-01 | 서울대학교산학협력단 | Nanocomposite of Biocompatible PHEMA derivatives/Ag having antibacterial and antifouling activity |
WO2016049131A1 (en) * | 2014-09-23 | 2016-03-31 | Attostat, Inc. | Antimicrobial compositions and methods |
US20200239709A1 (en) | 2017-05-12 | 2020-07-30 | Inhibit Coatings Limited | Composite resins containing silver nanoparticles |
EP3462526A1 (en) | 2017-09-27 | 2019-04-03 | Fritz-Haber-Institut Der Max-Planck-Gesellschaft | Atomically dispersed metal species in an ionic liquid on the surface of a carbon material having sp2 hybridization, and method for the preparation thereof |
Non-Patent Citations (54)
Title |
---|
A. K. CHATTERJEER. CHAKRABORTYT. BASU, NANOTECHNOLOGY, vol. 25, 2014, pages 13501 |
A. W. MAYZ. SHID. B. WIJAYASEKARAD. L. GINT. S. BAILEY, POLYM. CHEM., vol. 10, 2019, pages 751 |
B. A. ADERIBIGBE, MOLECULES, vol. 22, 2017, pages 1370 |
BALAGNA CRISTINA ET AL: "Virucidal effect against coronavirus SARS-CoV-2 of a silver nanocluster/ silica composite sputtered coating", OPEN CERAMICS 1, 6 June 2020 (2020-06-06), pages 1 - 3, XP055851692, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274986/pdf/main.pdf> [retrieved on 20211015] * |
C. A. P. BASTOSN. FARIAJ. WILLSP. MALMBERGN. SCHEERSP. REESJ. J. POWELL, NANOLMPACT, vol. 17, 2020, pages 100192 |
C. N. R. RAOG. U. KULKARNIP. J. THOMASP. P. EDWARDS, CHEM. SOC. REV., vol. 29, 2000, pages 27 |
CHARAN ET AL., EUROPEAN POLYMER JOURNAL, vol. 60, November 2014 (2014-11-01), pages 114 - 122, ISSN: 0014-3057 |
D. CHAKHALIANR. B. SHULTZC. E. MILESJ. KOHN, J. BIOMED. MATER. RES. - PART A, vol. 108, 2020, pages 1974 |
DZHARDIMALIEVA GULZHIAN I ET AL: "Preparation of metal-polymer nanocomposites by chemical reduction of metal ions: functions of polymer matrices", JOURNAL OF POLYMER RESEARCH, SPRINGER NETHERLANDS, DORDRECHT, vol. 25, no. 12, 13 November 2018 (2018-11-13), pages 1 - 65, XP036655452, ISSN: 1022-9760, [retrieved on 20181113], DOI: 10.1007/S10965-018-1646-8 * |
H. HEK. RAHIMIM. ZHONGA. MOURRAND. R. LUEBKEH. B. NULWALAM. MOLLERK. MATYJASZEWSKI, NAT. COMMUN., vol. 8, 2017, pages 14057 |
H. LINS. ZHANGJ. K. SUNM. ANTONIETTIJ. YUAN, POLYMER (GUILDF), vol. 202, 2020, pages 122640 |
H. ZHUC. ZHANGY. YIN, NANOTECHNOLOGY, vol. 16, 2005, pages 3079 |
I. DAS JANAP. KUMBHAKARS. BANERJEEC. C. GOWDAN. KEDIAS. K. KUILAS. BANERJEEN. C. DASA. K. DASI. MANNA, ACS APPL. NANO MATER., vol. 4, 2021, pages 352 |
J. QINJ. GUOQ. XUZ. ZHENGH. MAOF. YAN, ACS APPL. MATER. INTERFACES, vol. 9, 2017, pages 10504 |
J. XUL. ZHANGX. GAOH. BIEY. FUC. GAO, J. MEMB. SCI., vol. 491, 2015, pages 28 |
J. YUANM. ANTONIETTI, POLYMER (GUILDF), vol. 52, 2011, pages 1469 |
J. YUANS. SOLLM. DRECHSLERA. H. E. MULLERM. ANTONIETTI, J. AM. CHEM. SOC., vol. 133, 2011, pages 17556 |
J. ZHUA. ULIANAJ. WANGS. YUANJ. LIM. TIANK. SIMOENSA. VOLODINJ. LINK. BERNAERTS, J. MATER. CHEM. A, vol. 4, 2016, pages 13211 |
JAGARAN K. ET AL: "Nanomedicine for COVID-19: Potential of Copper Nanoparticles", BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, vol. 11, no. 3, 14 November 2020 (2020-11-14), pages 10716 - 10728, XP055900218, DOI: 10.33263/BRIAC113.1071610728 * |
K. GRYGIELJ. S. LEEK. SAKAUSHIM. ANTONIETTIJ. YUAN, ACS MACRO LETT, vol. 4, 2015, pages 1312 |
K. MADURAYR. PARBOOSING, BIOL. TRACE ELEM. RES., 2020 |
K. MANOJKUMARA. SIVARAMAKRISHNAK. VIJAYAKRISHNA, J. NANOPARTICLE RES, vol. 18, 2016, pages 1 |
K. MANOJKUMARD. MECERREYESD. TATONY. GNANOUK. VIJAYAKRISHNA, POLYM. CHEM., vol. 8, 2017, pages 3497 |
KHORSAND KHEIRABAD ATEFEH ET AL: "Colloidal dispersion of poly(ionic liquid)/Cu composite particles for protective surface coating against SAR-CoV-2", NANO SELECT, vol. 3, no. 1, 1 June 2021 (2021-06-01), pages 227 - 232, XP055899829, ISSN: 2688-4011, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1002/nano.202100069> DOI: 10.1002/nano.202100069 * |
L. KONGM. ZHANGY. ZHANGW. ZHANGX. ZHOUL. ZHANGX. WANG, POLYM. CHEM., vol. 11, 2020, pages 7429 |
M. BANACHJ. PULIT-PROCIAK, J. CLEAN. PROD., vol. 141, 2017, pages 1030 |
M. C. SPORTELLIM. IZZIE. A. KUKUSHKINAS. I. HOSSAINR. A. PICCAN. DITARANTON. CIOFF, NANOMATERIALS, vol. 10, 2020, pages 1 |
M. KRAMERN. PERIGNONR. HAAGJ. D. MARTYR. THOMANNN. L. DE VIGUERIEC. MINGOTAUD, MACROMOLECULES, vol. 38, 2005, pages 8308 |
M. RAIS. D. DESHMUKHA. P. INGLEI. R. GUPTAM. GALDIEROS. GALDIERO, CRIT. REV. MICROBIOL., vol. 42, 2016, pages 46 |
M. VINCENTR. E. DUVALP. HARTEMANNM. ENGELS-DEUTSCH: "124", J. APPL. MICROBIOL., 2018, pages 1032 |
MUÑOZ-BONILLA ALEXANDRA ET AL: "Poly(ionic liquid)s as antimicrobial materials", EUROPEAN POLYMER JOURNAL, PERGAMON PRESS LTD OXFORD, GB, vol. 105, 25 May 2018 (2018-05-25), pages 135 - 149, XP085430076, ISSN: 0014-3057, DOI: 10.1016/J.EURPOLYMJ.2018.05.027 * |
N. A. DHASC. P. RAJA. GEDANKEN, CHEM. MATER., vol. 10, 1998, pages 1446 |
O. DTUGOSZM. SOCHOCKAM. OCHNIKM. BANACH, J. COLLOID INTERFACE SCI., vol. 586, 2020, pages 807 |
P. G. JAMKHANDEN. W. GHULEA. H. BAMERM. G. KALASKAR, J. DRUG DELIV. SCI. TECHNOL., vol. 53, 2019, pages 101174 |
P. K. RAIZ. USMANIV. K. THAKURV. K. GUPTAY. K. MISHRA, CURR. RES. GREEN SUSTAIN. CHEM., vol. 3, 2020, pages 100011 |
PRABHU CHARAN K T ET AL: "Poly(ionic liquids) as "smart" stabilizers for metal nanop", EUROPEAN POLYMER JOURNAL, PERGAMON PRESS LTD OXFORD, GB, vol. 60, 16 September 2014 (2014-09-16), pages 114 - 122, XP029019980, ISSN: 0014-3057, DOI: 10.1016/J.EURPOLYMJ.2014.09.004 * |
R. A. SEQUEIRAN. SINGHM. M. PEREIRAN. A. CHUDASAMAS. BHATTACHARYAM. SHARMA, D. MONDALK. PRASAD, INT. J. BIOL. MACROMOL., vol. 120, 2018, pages 378 |
R. SARDARJ. W. PARKJ. S. SHUMAKER-PARRY, LANGMUIR, vol. 23, 2007, pages 11883 |
R. VAZQUEZ-MUNOZM. J. ARELLANO-JIMENEZJ. L. LOPEZ-RIBOT, BMC BIOMED. ENG., vol. 2, 2020, pages 1 |
S. DINGZ. LYUX. NIUY. ZHOUD. LIUM. FALAHATID. DUY. LIN, BIOSENS. BIOELECTRON., vol. 149, 2020, pages 111830 |
S. SARKARE. GUIBALF. QUIGNARDA. K. SENGUPTA, J. NANOPARTICLE RES., 2012, pages 14 |
S. TALEBIANG. G. WALLACEA. SCHROEDERF. STELLACCIJ. CONDE, NAT. NANOTECHNOL., vol. 15, 2020, pages 618 |
W. QIANJ. TEXTERF. YAN, CHEM. SOC. REV., vol. 46, 2017, pages 1124 |
W. XUP. A. LEDINV. V. SHEVCHENKOV. V. TSUKRUK, ACS APPL. MATER. INTERFACES, vol. 7, 2015, pages 12570 |
W. ZHANGS. WEIY. WUY. L. WANGM. ZHANGD. ROYH. WANGJ. YUANQ. ZHAO, ACS NANO, vol. 13, 2019, pages 10261 |
W. ZHANGZ. KOCHOVSKIY. LUB. V. K. J. SCHMIDTM. ANTONIETTIJ. YUAN, ACS NANO, vol. 10, 2016, pages 7731 |
X. FENGK. ZHANGP. CHENX. SUIM. A. HEMPENIUSB. LIEDBERGG. J. VANCSO, MACROMOL. RAPID COMMUN., vol. 37, 2016, pages 1939 |
Y. GAOY. WANGY. YANK. TANGC. F. DING, J. SEP. SCI., vol. 43, 2020, pages 766 |
Y. MENM. DRECHSLERJ. YUAN, MACROMOL. RAPID COMMUN., vol. 34, 2013, pages 1721 |
Y. MENM. SIEBENBURGERX. QIUM. ANTONIETTIJ. YUAN, J. MATER. CHEM. A, vol. 1, 2013, pages 11887 |
Y. WANGY. SHAOH. WANGJ. YUAN, ACCOUNTS MATER. RES., vol. 1, 2020, pages 16 |
Y. YUC. YUT. YINS. OUX. SUNX. WENL. ZHANGD. TANGX. YIN, BIOSENS. BIOELECTRON., vol. 87, 2017, pages 278 |
Z. SUNK. (KEN) OSTRIKOV, SUSTAIN. MATER. TECHNOL., vol. 25, 2020, pages e00203 |
ZHANG SU-YUN ET AL: "Poly(ionic liquid) composites", CHEMICAL SOCIETY REVIEWS, vol. 49, no. 6, 1 January 2020 (2020-01-01), UK, pages 1726 - 1755, XP055899805, ISSN: 0306-0012, DOI: 10.1039/C8CS00938D * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xiang et al. | Mussel-inspired immobilization of zwitterionic silver nanoparticles toward antibacterial cotton gauze for promoting wound healing | |
Shanmugam et al. | Biomimetic TiO2-chitosan/sodium alginate blended nanocomposite scaffolds for tissue engineering applications | |
Oliver et al. | Enhancing the antimicrobial and antibiofilm effectiveness of silver nanoparticles prepared by green synthesis | |
Biddeci et al. | Halloysite nanotubes loaded with peppermint essential oil as filler for functional biopolymer film | |
Cheng et al. | Biopolymer functionalized reduced graphene oxide with enhanced biocompatibility via mussel inspired coatings/anchors | |
Mosaiab et al. | Recyclable and stable silver deposited magnetic nanoparticles with poly (vinyl pyrrolidone)-catechol coated iron oxide for antimicrobial activity | |
Liakos et al. | All natural cellulose acetate—Lemongrass essential oil antimicrobial nanocapsules | |
Verma et al. | Citrate-functionalized hydroxyapatite nanoparticles for pH-responsive drug delivery | |
Ferreira et al. | Antimicrobial coatings based on poly (dimethyl siloxane) and silver nanoparticles by solution blow spraying | |
Sharaf et al. | A new strategy to integrate silver nanowires with waterborne coating to improve their antimicrobial and antiviral properties | |
KR20140010433A (en) | Process for the treatment of synthetic textiles with cationic biocides | |
TW201229223A (en) | Hydrophilic film for metal materials, hydrophilization treatment agent, and hydrophilization treatment method | |
Zheng et al. | Luminescent zinc oxide nanoparticles: from stabilization to slow digestion depending on the nature of polymer coating | |
CN111333862B (en) | Antiviral emulsion composition, coating and preparation method thereof | |
Kim et al. | Synthesis, characterization, and antibacterial applications of novel copolymeric silver nanocomposite hydrogels | |
Varaprasad et al. | Development of microbial resistant Carbopol nanocomposite hydrogels via a green process | |
Khorsand Kheirabad et al. | Colloidal dispersion of poly (ionic liquid)/Cu composite particles for protective surface coating against SAR‐CoV‐2 | |
Karabulut et al. | Surface modification of 316L stainless steel with multifunctional locust gum/polyethylene glycol-silver nanoparticles using different coating methods | |
JP2023139141A (en) | Compositions and methods for reducing odor | |
WO2022124973A1 (en) | A colloidal composite particle dispersion for use in an antimicrobial and virucidal surface coating | |
Kuang et al. | Biomimetic FeCo@ PDA nanozyme platform with Fenton catalytic activity as efficient antibacterial agent | |
Keum et al. | Impeding the medical protective clothing contamination by a spray coating of trifunctional polymers | |
Ma et al. | Controllable synthesis of ultrasmall copper nanoparticles decorated fullerenol composite for antibacterial application and wound healing under visible light | |
Meng et al. | Polymeric nanoparticles-based multi-functional coatings on NiTi alloy with nickel ion release control, cytocompatibility, and antibacterial performance | |
Li et al. | Hemocompatible, antioxidative and antibacterial polypropylene prepared by attaching silver nanoparticles capped with TPGS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21831133 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21831133 Country of ref document: EP Kind code of ref document: A1 |